user_variable,user_description,matched_text,uid,relevance_score,llm_alignment,match
submitter_id,A project-specific identifier for a node. This property is the calling card/nickname/alias for a unit of submission. It can be used in place of the UUID for identifying or recalling a node.,UNIQUE COMMUNITY IDENTIFIER,242980,0.33884242,"['1. UNIQUE COMMUNITY IDENTIFIER - This variable is used to uniquely identify different communities within the dataset. It may not be directly relevant to the new variable as it focuses on community-level identification rather than individual node identification.', '2. UNIQUE SUBJECT ID - This variable is used to uniquely identify individual subjects within the dataset. While it is more closely related to the concept of individual identification, it may not be the best fit for harmonizing the new variable as it is specific to subjects rather than nodes.', '3. UNIQUE SUBJECT IDENTIFIER - Similar to the UNIQUE SUBJECT ID, this variable is used to uniquely identify individual subjects within the dataset. It may not be the best fit for harmonizing the new variable as it is specific to subjects rather than nodes.', '', 'SELECTED: UNIQUE SUBJECT ID', 'ALIGNMENT: To align the new variable with the selected existing variable (UNIQUE SUBJECT ID), you can consider using a similar format for the node identifier. Ensure that the new variable follows the same principles of uniqueness and individual identification as the UNIQUE SUBJECT ID. Additionally, you may need to establish a mapping or cross-reference system between the new variable and the UNIQUE SUBJECT ID to maintain consistency and coherence within the dataset.']",
submitter_id,A project-specific identifier for a node. This property is the calling card/nickname/alias for a unit of submission. It can be used in place of the UUID for identifying or recalling a node.,UNIQUE SUBJECT ID,242989,0.26683462,,
submitter_id,A project-specific identifier for a node. This property is the calling card/nickname/alias for a unit of submission. It can be used in place of the UUID for identifying or recalling a node.,UNIQUE SUBJECT IDENTIFIER,242990,0.26435837,,
participant_id,Unique identifier that can be used to retrieve more information for a participant.,PARTICIPANT IDENTIFICATION,177036,0.94407386,"['1. PARTICIPANT IDENTIFICATION - This variable likely serves as a unique identifier for each participant in the dataset.', '2. PARTICIPANT ID - This variable also likely serves as a unique identifier for each participant in the dataset.', '3. PARTICIPANT ID NUMBER - This variable may also serve as a unique identifier for each participant in the dataset.', '', 'SELECTED: PARTICIPANT ID', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the unique identifier assigned to each participant is consistent and accurately recorded across all data entries. This will help maintain data integrity and facilitate data retrieval for each participant.']",
participant_id,Unique identifier that can be used to retrieve more information for a participant.,PARTICIPANT ID,177033,0.9413314,,
participant_id,Unique identifier that can be used to retrieve more information for a participant.,PARTICIPANT ID NUMBER,177035,0.8513359,,
consent_codes,"Data Use Restrictions that are used to indicate permissions/restrictions for datasets and/or materials, and relates to the purposes for which datasets and/or material might be removed, stored or used.Based on the Data Use Ontology : see http://www.obofoundry.org/ontology/duo.htmlGRU - For general research use for any research purpose. Example of usage: This includes but is not limited to: health/medical/biomedical purposes, fundamental biology research, the study of population origins or ancestry, statistical methods and algorithms development, and social-sciences research.HMB - Use of the data is limited to health/medical/biomedical purposes; does not include the study of population origins or ancestry.DS-X - Use of the data must be related to [disease].NPU - Use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.IRB - Requestor must provide documentation of local IRB/REC approval.",PERMISSION FOR NON-PROFIT USE OF DATA,180823,0.9804313,"['1. PERMISSION FOR NON-PROFIT USE OF DATA - This variable indicates permission for non-profit organizations to use the data for non-commercial purposes. It aligns with the concept of NPU in the new variable, which specifies that the data can only be used by not-for-profit organizations.', '', '2. ANY PERMISSION FOR USE - NON-GENETIC DATA - This variable indicates general permission for use of non-genetic data. While it is relevant to the overall concept of data use permissions, it does not specifically align with the restrictions and permissions outlined in the new variable.', '', '3. PERMISSION FOR FOR-PROFIT USE OF DATA - This variable indicates permission for for-profit organizations to use the data. It is not aligned with the NPU restriction specified in the new variable.', '', 'SELECTED: PERMISSION FOR NON-PROFIT USE OF DATA', 'ALIGNMENT: To align the new variable with the existing variable ""Permission for Non-Profit Use of Data,"" ensure that the data being added to the repository is only accessible to not-for-profit organizations and is intended for non-commercial use. This alignment will help maintain consistency in data use permissions within the repository.']",
consent_codes,"Data Use Restrictions that are used to indicate permissions/restrictions for datasets and/or materials, and relates to the purposes for which datasets and/or material might be removed, stored or used.Based on the Data Use Ontology : see http://www.obofoundry.org/ontology/duo.htmlGRU - For general research use for any research purpose. Example of usage: This includes but is not limited to: health/medical/biomedical purposes, fundamental biology research, the study of population origins or ancestry, statistical methods and algorithms development, and social-sciences research.HMB - Use of the data is limited to health/medical/biomedical purposes; does not include the study of population origins or ancestry.DS-X - Use of the data must be related to [disease].NPU - Use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.IRB - Requestor must provide documentation of local IRB/REC approval.",ANY PERMISSION FOR USE - NON-GENETIC DATA,21660,0.9795506,,
consent_codes,"Data Use Restrictions that are used to indicate permissions/restrictions for datasets and/or materials, and relates to the purposes for which datasets and/or material might be removed, stored or used.Based on the Data Use Ontology : see http://www.obofoundry.org/ontology/duo.htmlGRU - For general research use for any research purpose. Example of usage: This includes but is not limited to: health/medical/biomedical purposes, fundamental biology research, the study of population origins or ancestry, statistical methods and algorithms development, and social-sciences research.HMB - Use of the data is limited to health/medical/biomedical purposes; does not include the study of population origins or ancestry.DS-X - Use of the data must be related to [disease].NPU - Use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.IRB - Requestor must provide documentation of local IRB/REC approval.",PERMISSION FOR FOR-PROFIT USE OF DATA,180821,0.97923523,,
amputation_type,"If amputated, the amputation type for leg, above the knee or below the knee.  ","13B2. LOWER EXTREMITY AMPUTATION (TOE, FOREFOOT, HEEL, BELOW THE KNEE)",4733,0.8856315,"['Existing Variables:', '1. AMPUTATION OF LOWER EXTREMITY - This variable captures any type of amputation in the lower extremity, which includes toe, forefoot, heel, below the knee, and above the knee.', '2. AMPUTATION - This variable is a general indicator of any type of amputation, not specific to the lower extremity.', '3. AMPUTATION OF LEG - This variable specifically focuses on amputations in the leg, which can include above the knee or below the knee.', '', 'SELECTED: AMPUTATION OF LOWER EXTREMITY', 'ALIGNMENT: To align the new variable ""If amputated, the amputation type for leg, above the knee or below the knee"" with the selected existing variable ""Amputation of Lower Extremity"", ensure that the new variable captures the specific details of the amputation type in the lower extremity, including whether it is above the knee or below the knee. This alignment will help maintain consistency and specificity in the data repository.']",
amputation_type,"If amputated, the amputation type for leg, above the knee or below the knee.  ",AMPUTATION OF LOWER EXTREMITY,19693,0.23231015,,
amputation_type,"If amputated, the amputation type for leg, above the knee or below the knee.  ",AMPUTATION,19692,0.1183851,,
cohort_id,"The study subgroup that the participant belongs to. This indicates whether the participant was a postmortem donor, an organ donor, or a surgical donor.  ",DONOR BLOOD GROUP,75719,0.6977119,"['1. DONOR BLOOD GROUP - This existing variable is relevant as it also pertains to information about the donor, specifically their blood group. This could potentially be aligned with the new variable to provide additional donor-related information.', '', ""2. DERIVED DUPLICATE DONOR RECIPIENT (BASED ON DONOR'S STUDY ARM AND RECIPIENT) - This existing variable may not be directly related to the new variable as it focuses on the relationship between the donor and recipient based on study arm. It may not align well with the study subgroup information."", '', '3. SUBJECT RECEIVED A STUDY TRANSPLANT (0=NO, 1=YES) - This existing variable is related to whether the subject received a study transplant or not. While it provides information on the transplant status, it may not directly align with the study subgroup information.', '', 'SELECTED: DONOR BLOOD GROUP', 'ALIGNMENT: To align the new variable ""The study subgroup that the participant belongs to"" with the selected existing variable ""DONOR BLOOD GROUP,"" you can consider incorporating additional details about the participant\'s study subgroup within the existing donor information. This could involve adding specific categories or codes for postmortem donor, organ donor, or surgical donor within the donor blood group variable to capture the study subgroup information effectively. Additionally, you may need to update the data collection forms or data entry procedures to ensure accurate recording of the study subgroup information within the donor blood group variable.']",
cohort_id,"The study subgroup that the participant belongs to. This indicates whether the participant was a postmortem donor, an organ donor, or a surgical donor.  ",DERIVED DUPLICATE DONOR RECIPIENT (BASED ON DONOR'S STUDY ARM AND RECIPIENT),68680,0.45259643,,
cohort_id,"The study subgroup that the participant belongs to. This indicates whether the participant was a postmortem donor, an organ donor, or a surgical donor.  ","SUBJECT RECEIVED A STUDY TRANSPLANT (0=NO, 1=YES)",226487,0.3455468,,
data_submission_guid,"A Globally Unique IDentifier (GUID) provided by the data submitter, used to identify this subject across multiple projects, commons, etc.",UNIQUE SUBJECT IDENTIFIER,242990,0.9619649,"['Existing Variables:', '1. UNIQUE SUBJECT IDENTIFIER - This variable is used to uniquely identify each subject in the data repository.', '2. UNIQUE SUBJECT ID - Similar to the unique subject identifier, this variable is also used for subject identification.', '3. PUBLIC SUBJECT ID - Another variable used for subject identification, potentially for public access purposes.', '', 'SELECTED: UNIQUE SUBJECT IDENTIFIER', 'ALIGNMENT: To align the new variable ""A Globally Unique IDentifier (GUID)"" with the existing variable ""UNIQUE SUBJECT IDENTIFIER"", ensure that the format and structure of the GUID provided by the data submitter matches the requirements of the unique subject identifier in the data repository. This may involve standardizing the format or ensuring that the GUID is unique and consistent across all projects and datasets. Additionally, consider any privacy or security measures in place for subject identification.']",
data_submission_guid,"A Globally Unique IDentifier (GUID) provided by the data submitter, used to identify this subject across multiple projects, commons, etc.",UNIQUE SUBJECT ID,242989,0.8098782,,
data_submission_guid,"A Globally Unique IDentifier (GUID) provided by the data submitter, used to identify this subject across multiple projects, commons, etc.",PUBLIC SUBJECT ID,189115,0.66235983,,
derived_parent_subject_id,Unique subject identifier associated with parent project; derived from parent accession and submitted subject ID.,UNIQUE SUBJECT IDENTIFIER,242990,0.97622,"['Existing Variables:', '1. UNIQUE SUBJECT IDENTIFIER - This variable is used to uniquely identify each subject in the data repository. It is crucial for linking different datasets and ensuring data integrity.', '2. UNIQUE SUBJECT ID - Similar to the unique subject identifier, this variable serves the same purpose of uniquely identifying subjects in the repository.', '3. SUBJECT ID - Another variable used to identify subjects in the repository, although it may not be unique across different datasets.', '', 'SELECTED: UNIQUE SUBJECT IDENTIFIER', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the unique subject identifier associated with the parent project is structured in a consistent format and follows the same conventions as the existing unique subject identifier. This will help maintain data integrity and facilitate data linkage across different datasets.']",
derived_parent_subject_id,Unique subject identifier associated with parent project; derived from parent accession and submitted subject ID.,UNIQUE SUBJECT ID,242989,0.951504,,
derived_parent_subject_id,Unique subject identifier associated with parent project; derived from parent accession and submitted subject ID.,SUBJECT ID,226431,0.78282857,,
derived_topmed_subject_id,Unique subject identifier associated with TOPMed project; derived from TOPMed accession and submitted subject ID.,UNIQUE SUBJECT IDENTIFIER,242990,0.9887988,"['Existing Variables:', '1. UNIQUE SUBJECT IDENTIFIER - This variable is used to uniquely identify each subject in the data repository. It is crucial for linking different data points related to the same individual.', '2. UNIQUE SUBJECT ID - Similar to the unique subject identifier, this variable serves the purpose of uniquely identifying each subject in the dataset.', '3. DEIDENTIFIED DERIVED PATIENT ID - This variable is used to assign a unique identifier to each patient while maintaining their anonymity.', '', 'SELECTED: UNIQUE SUBJECT IDENTIFIER', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the unique subject identifier associated with the TOPMed project is structured in a similar format to the existing unique subject identifier in the repository. This will facilitate seamless integration and harmonization of the new data with the existing dataset. Additionally, cross-reference the TOPMed accession and submitted subject ID with the unique subject identifier to maintain consistency and accuracy in data linkage.']",
derived_topmed_subject_id,Unique subject identifier associated with TOPMed project; derived from TOPMed accession and submitted subject ID.,UNIQUE SUBJECT ID,242989,0.97520185,,
derived_topmed_subject_id,Unique subject identifier associated with TOPMed project; derived from TOPMed accession and submitted subject ID.,DEIDENTIFIED DERIVED PATIENT ID,68150,0.7210563,,
eligibility,A verification field of whether the Donor has met the overall eligibility criteria for GTEx collection based on answers to eligibility questions. All Eligibility conditions require confirmation from the donor procurement team (staff team where tissue collection and data abstraction takes place) and must be met in order for donor to eligible.  ,ELIGIBILITY VERIFICATION,81775,0.94957596,"['1. ELIGIBILITY VERIFICATION - This existing variable likely captures general eligibility verification for donors, which may include meeting certain criteria or standards for donation. It is relevant to the new variable as it also pertains to verifying if the donor has met eligibility criteria.', '', '2. DONOR MEETS INCL CRITERIA - This existing variable specifically focuses on whether the donor meets the inclusion criteria for donation. While it is related to eligibility, it may not capture the overall eligibility verification process as comprehensively as the new variable.', '', '3. GD01: D3. DOES DONOR MEET STANDARD BLOOD CENTER CRITERIA - This existing variable seems to specifically address whether the donor meets the standard criteria set by blood centers. While it may involve some eligibility verification, it may not align perfectly with the broader eligibility criteria for the GTEx collection.', '', 'SELECTED: ELIGIBILITY VERIFICATION', 'ALIGNMENT: To align the new variable with the existing variable ""ELIGIBILITY VERIFICATION,"" ensure that the verification field captures all necessary eligibility conditions for the GTEx collection. This may involve confirming eligibility criteria with the donor procurement team and ensuring that all conditions are met for the donor to be considered eligible for donation. Additionally, consider incorporating any specific criteria or standards relevant to the GTEx collection process into the verification process.']",
eligibility,A verification field of whether the Donor has met the overall eligibility criteria for GTEx collection based on answers to eligibility questions. All Eligibility conditions require confirmation from the donor procurement team (staff team where tissue collection and data abstraction takes place) and must be met in order for donor to eligible.  ,DONOR MEETS INCL CRITERIA,75867,0.94122344,,
eligibility,A verification field of whether the Donor has met the overall eligibility criteria for GTEx collection based on answers to eligibility questions. All Eligibility conditions require confirmation from the donor procurement team (staff team where tissue collection and data abstraction takes place) and must be met in order for donor to eligible.  ,GD01: D3. DOES DONOR MEET STANDARD BLOOD CENTER CRITERIA,102932,0.82810634,,
geographic_site,"""Site where the subject was recruted. ARIC_A=field center A representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_B=field center B representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_C=field center C representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_D=field center D representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), CARDIA_1=field center 1 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_2=field center 2 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_3=field center 3 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_4=field center 4 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CHS_BOWMAN.GRAY=clinic at Bowman Gray University (Forsyth County, NC, USA) for CHS (Cardiovascular Health Study), CHS_DAVIS=clinic at Davis University (Sacramento County, CA, USA) for CHS (Cardiovascular Health Study), CHS_HOPKINS=clinic at Johns Hopkins University (Washington County, MD, USA) for CHS (Cardiovascular Health Study), CHS_PITT=clinic at University of Pittsburgh (Pittsburgh, PA, USA) for CHS (Cardiovascular Health Study), COPDGene_C01=clinical center C01 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C02=clinical center C02 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C03=clinical center C03 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C04=clinical center C04 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C05=clinical center C05 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C06=clinical center C06 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C07=clinical center C07 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C08=clinical center C08 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C09=clinical center C09 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C10=clinical center C10 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C11=clinical center C11 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C12=clinical center C12 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C13=clinical center C13 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C14=clinical center C14 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C15=clinical center C15 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C16=clinical center C16 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C17=clinical center C17 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C18=clinical center C18 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C19=clinical center C19 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C20=clinical center C20 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C21=clinical center C21 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), GENOA_MN=recruitment from Rochester, MN, US, GENOA_MS=recruitment from Jackson, MS, US, GOLDN_MN=recruitment center at Minneapolis, MN, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), GOLDN_UT=recruitment center at Salt Lake City, UT, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), HCHS_SOL_Bronx=recruitment center Bronx, NY, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Chicago=recruitment center Chicago, IL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Miami=recruitment center Miami, FL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_SanDiego=recruitment center San Diego, CA, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), JHS_Hinds=recruitment from urban and rural areas of Hinds county, MS, USA for JHS (Jackson Heart Study), JHS_Madison=recruitment from urban and rural areas of Madison county, MS, USA for JHS (Jackson Heart Study), JHS_Rankin=recruitment from urban and rural areas of Rankin county, MS, USA for JHS (Jackson Heart Study), JHS_Unknown=recruitment from unknown county in MS, USA for JHS (Jackson Heart Study), Mayo_VTE_Midwest_US=state of residence (at time of enrollment for Mayo_VTE study) is in the South region of the USA as defined by the Census Bureau, Mayo_VTE_Northeast_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Northeast region of the USA as defined by the Census Bureau, Mayo_VTE_non_US=state of residence (at time of enrollment for Mayo_VTE study) is from a country outside the USA, Mayo_VTE_South_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Midwest region of the USA as defined by the Census Bureau, Mayo_VTE_West_US=state of residence (at time of enrollment for Mayo_VTE study) is in the West region of the USA as defined by the Census Bureau, MESA_COL=field center/baseline clinic at Columbia University, NY, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_JHU=field center/baseline clinic at Johns Hopkins University, MD, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_NWU=field center/baseline clinic at Northwestern University, IL, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UCLA=field center/baseline clinic at University of California, Los Angeles, CA, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UMN=field center/baseline clinic at University of Minnesota, MN, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_WFU=field center/baseline clinic at Wake Forest University, NC, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), SAS_Apia.urban=recruitment census region of Apia Urban Area in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_NW.Upola=recruitment census region of Northwest Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_rest.Upola=recruitment census region including rest of Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_Savaii=recruitment census region of Savaii in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), WHI_Midwest=recruitment from Midwest region of the USA for WHI (Womens Health Initiative), WHI_Northeast=recruitment from Northeast region of the USA for WHI (Womens Health Initiative), WHI_South=recruitment from South region of the USA for WHI (Womens Health Initiative), WHI_West=recruitment from West region of the USA for WHI (Womens Health Initiative)"" (HARMONIZED)",IS PATIENT ADDRESS IN ARIC COMMUNITY SURVEILLANCE CATCHMENT AREA? Q5B,127229,0.34543642,"['1. ARIC SURVEILLANCE EVENT ID (CIR) - This variable identifies the unique event ID associated with the ARIC surveillance data. It is relevant as it helps track and link events within the ARIC study.', '', '2. FRAMINGHAM HEART STUDY PARTICIPANT COHORT IDENTIFIER - This variable identifies the cohort to which a participant belongs in the Framingham Heart Study. It may be relevant for categorizing participants in the new study.', '', ""3. IS PATIENT ADDRESS IN ARIC COMMUNITY SURVEILLANCE CATCHMENT AREA? Q5B - This variable indicates whether a patient's address falls within the catchment area for ARIC community surveillance. While not directly related to the site of recruitment, it provides information on the geographical location of participants."", '', 'SELECTED: ARIC SURVEILLANCE EVENT ID (CIR)', 'ALIGNMENT: To align the new variable ""Site where the subject was recruited"" with the existing variable ""ARIC SURVEILLANCE EVENT ID (CIR),"" you can create a mapping table that links the specific field centers (ARIC_A, ARIC_B, ARIC_C, ARIC_D) to their corresponding event IDs. This mapping will help harmonize the new variable with the existing variable structure in the repository.']",
geographic_site,"""Site where the subject was recruted. ARIC_A=field center A representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_B=field center B representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_C=field center C representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_D=field center D representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), CARDIA_1=field center 1 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_2=field center 2 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_3=field center 3 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_4=field center 4 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CHS_BOWMAN.GRAY=clinic at Bowman Gray University (Forsyth County, NC, USA) for CHS (Cardiovascular Health Study), CHS_DAVIS=clinic at Davis University (Sacramento County, CA, USA) for CHS (Cardiovascular Health Study), CHS_HOPKINS=clinic at Johns Hopkins University (Washington County, MD, USA) for CHS (Cardiovascular Health Study), CHS_PITT=clinic at University of Pittsburgh (Pittsburgh, PA, USA) for CHS (Cardiovascular Health Study), COPDGene_C01=clinical center C01 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C02=clinical center C02 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C03=clinical center C03 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C04=clinical center C04 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C05=clinical center C05 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C06=clinical center C06 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C07=clinical center C07 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C08=clinical center C08 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C09=clinical center C09 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C10=clinical center C10 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C11=clinical center C11 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C12=clinical center C12 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C13=clinical center C13 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C14=clinical center C14 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C15=clinical center C15 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C16=clinical center C16 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C17=clinical center C17 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C18=clinical center C18 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C19=clinical center C19 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C20=clinical center C20 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C21=clinical center C21 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), GENOA_MN=recruitment from Rochester, MN, US, GENOA_MS=recruitment from Jackson, MS, US, GOLDN_MN=recruitment center at Minneapolis, MN, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), GOLDN_UT=recruitment center at Salt Lake City, UT, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), HCHS_SOL_Bronx=recruitment center Bronx, NY, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Chicago=recruitment center Chicago, IL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Miami=recruitment center Miami, FL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_SanDiego=recruitment center San Diego, CA, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), JHS_Hinds=recruitment from urban and rural areas of Hinds county, MS, USA for JHS (Jackson Heart Study), JHS_Madison=recruitment from urban and rural areas of Madison county, MS, USA for JHS (Jackson Heart Study), JHS_Rankin=recruitment from urban and rural areas of Rankin county, MS, USA for JHS (Jackson Heart Study), JHS_Unknown=recruitment from unknown county in MS, USA for JHS (Jackson Heart Study), Mayo_VTE_Midwest_US=state of residence (at time of enrollment for Mayo_VTE study) is in the South region of the USA as defined by the Census Bureau, Mayo_VTE_Northeast_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Northeast region of the USA as defined by the Census Bureau, Mayo_VTE_non_US=state of residence (at time of enrollment for Mayo_VTE study) is from a country outside the USA, Mayo_VTE_South_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Midwest region of the USA as defined by the Census Bureau, Mayo_VTE_West_US=state of residence (at time of enrollment for Mayo_VTE study) is in the West region of the USA as defined by the Census Bureau, MESA_COL=field center/baseline clinic at Columbia University, NY, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_JHU=field center/baseline clinic at Johns Hopkins University, MD, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_NWU=field center/baseline clinic at Northwestern University, IL, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UCLA=field center/baseline clinic at University of California, Los Angeles, CA, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UMN=field center/baseline clinic at University of Minnesota, MN, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_WFU=field center/baseline clinic at Wake Forest University, NC, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), SAS_Apia.urban=recruitment census region of Apia Urban Area in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_NW.Upola=recruitment census region of Northwest Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_rest.Upola=recruitment census region including rest of Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_Savaii=recruitment census region of Savaii in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), WHI_Midwest=recruitment from Midwest region of the USA for WHI (Womens Health Initiative), WHI_Northeast=recruitment from Northeast region of the USA for WHI (Womens Health Initiative), WHI_South=recruitment from South region of the USA for WHI (Womens Health Initiative), WHI_West=recruitment from West region of the USA for WHI (Womens Health Initiative)"" (HARMONIZED)",ARIC SURVEILLANCE EVENT ID (CIR),23167,0.3306873,,
geographic_site,"""Site where the subject was recruted. ARIC_A=field center A representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_B=field center B representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_C=field center C representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_D=field center D representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), CARDIA_1=field center 1 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_2=field center 2 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_3=field center 3 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_4=field center 4 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CHS_BOWMAN.GRAY=clinic at Bowman Gray University (Forsyth County, NC, USA) for CHS (Cardiovascular Health Study), CHS_DAVIS=clinic at Davis University (Sacramento County, CA, USA) for CHS (Cardiovascular Health Study), CHS_HOPKINS=clinic at Johns Hopkins University (Washington County, MD, USA) for CHS (Cardiovascular Health Study), CHS_PITT=clinic at University of Pittsburgh (Pittsburgh, PA, USA) for CHS (Cardiovascular Health Study), COPDGene_C01=clinical center C01 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C02=clinical center C02 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C03=clinical center C03 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C04=clinical center C04 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C05=clinical center C05 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C06=clinical center C06 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C07=clinical center C07 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C08=clinical center C08 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C09=clinical center C09 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C10=clinical center C10 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C11=clinical center C11 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C12=clinical center C12 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C13=clinical center C13 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C14=clinical center C14 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C15=clinical center C15 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C16=clinical center C16 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C17=clinical center C17 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C18=clinical center C18 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C19=clinical center C19 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C20=clinical center C20 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C21=clinical center C21 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), GENOA_MN=recruitment from Rochester, MN, US, GENOA_MS=recruitment from Jackson, MS, US, GOLDN_MN=recruitment center at Minneapolis, MN, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), GOLDN_UT=recruitment center at Salt Lake City, UT, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), HCHS_SOL_Bronx=recruitment center Bronx, NY, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Chicago=recruitment center Chicago, IL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Miami=recruitment center Miami, FL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_SanDiego=recruitment center San Diego, CA, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), JHS_Hinds=recruitment from urban and rural areas of Hinds county, MS, USA for JHS (Jackson Heart Study), JHS_Madison=recruitment from urban and rural areas of Madison county, MS, USA for JHS (Jackson Heart Study), JHS_Rankin=recruitment from urban and rural areas of Rankin county, MS, USA for JHS (Jackson Heart Study), JHS_Unknown=recruitment from unknown county in MS, USA for JHS (Jackson Heart Study), Mayo_VTE_Midwest_US=state of residence (at time of enrollment for Mayo_VTE study) is in the South region of the USA as defined by the Census Bureau, Mayo_VTE_Northeast_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Northeast region of the USA as defined by the Census Bureau, Mayo_VTE_non_US=state of residence (at time of enrollment for Mayo_VTE study) is from a country outside the USA, Mayo_VTE_South_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Midwest region of the USA as defined by the Census Bureau, Mayo_VTE_West_US=state of residence (at time of enrollment for Mayo_VTE study) is in the West region of the USA as defined by the Census Bureau, MESA_COL=field center/baseline clinic at Columbia University, NY, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_JHU=field center/baseline clinic at Johns Hopkins University, MD, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_NWU=field center/baseline clinic at Northwestern University, IL, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UCLA=field center/baseline clinic at University of California, Los Angeles, CA, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UMN=field center/baseline clinic at University of Minnesota, MN, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_WFU=field center/baseline clinic at Wake Forest University, NC, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), SAS_Apia.urban=recruitment census region of Apia Urban Area in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_NW.Upola=recruitment census region of Northwest Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_rest.Upola=recruitment census region including rest of Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_Savaii=recruitment census region of Savaii in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), WHI_Midwest=recruitment from Midwest region of the USA for WHI (Womens Health Initiative), WHI_Northeast=recruitment from Northeast region of the USA for WHI (Womens Health Initiative), WHI_South=recruitment from South region of the USA for WHI (Womens Health Initiative), WHI_West=recruitment from West region of the USA for WHI (Womens Health Initiative)"" (HARMONIZED)",FRAMINGHAM HEART STUDY PARTICIPANT COHORT IDENTIFIER,100179,0.28051782,,
index_date,"""Indicates whether the time point reference begins at the donor's actual death, presumed death, or when the cross clamp was applied in the case of surgical donors.""",TIME OF DEATH,234515,0.6204491,"['Existing Variables:', '1. TIME OF DEATH - This variable records the exact time of death for a patient.', '2. DNR TIME (RELATIVE TO EDARTM) - This variable indicates the time of a ""do not resuscitate"" order relative to the time of emergency department admission.', '3. TIME OF CLINICAL DEATH - This variable records the time of clinical death, which may differ from the actual time of death.', '', 'SELECTED: TIME OF DEATH', 'ALIGNMENT: To align the new variable with the existing variable ""TIME OF DEATH,"" ensure that the time point reference for the new variable also records the exact time of death for the donor. This alignment will provide consistency in recording time-related data in the repository.']",
index_date,"""Indicates whether the time point reference begins at the donor's actual death, presumed death, or when the cross clamp was applied in the case of surgical donors.""",DNR TIME (RELATIVE TO EDARTM),74013,0.46247303,,
index_date,"""Indicates whether the time point reference begins at the donor's actual death, presumed death, or when the cross clamp was applied in the case of surgical donors.""",TIME OF CLINICAL DEATH,234449,0.35655868,,
transplanted_organ,"If the Donor was an Organ Donor, which Organs were donated.",BONE MARROW DONOR,35699,0.44960406,"['Existing Variables:', '1. BONE MARROW DONOR - This variable indicates whether the donor provided bone marrow for a transplant.', '2. WHAT ORGAN WAS TRANSPLANTED? - This variable specifies the organ that was transplanted from the donor.', '3. BLOOD TYPE OF DONOR - This variable describes the blood type of the donor.', '', 'SELECTED: WHAT ORGAN WAS TRANSPLANTED?', 'ALIGNMENT: To align the new variable ""If the Donor was an Organ Donor, which Organs were donated"" with the existing variable ""WHAT ORGAN WAS TRANSPLANTED?"", you can create a subcategory within the existing variable that lists all the organs donated by the organ donor. This will ensure that the new variable is harmonized with the existing variable in the data repository.']",
transplanted_organ,"If the Donor was an Organ Donor, which Organs were donated.",WHAT ORGAN WAS TRANSPLANTED?,254733,0.26779097,,
transplanted_organ,"If the Donor was an Organ Donor, which Organs were donated.",BLOOD TYPE OF DONOR,34900,0.14535783,,
unit_geographic_site,"harmonization unit for site (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNIT HAS A MATCH [SITE'S OPINION],242996,0.9967523,"['Existing Variables:', '1. UNIT - This variable likely refers to a unit of measurement or a specific unit within a study protocol. It may be used to standardize measurements or observations across different studies.', '2. OBSERVATION UNIT - This variable could represent a unit of observation within a study, such as a specific time point or location where data is collected. It helps organize and categorize data for analysis.', '3. HARMONIZATION UNIT - This variable may be related to the concept of harmonizing data across different studies or datasets. It could involve standardizing variables or protocols to ensure consistency and comparability.', '', 'SELECTED: UNIT', 'ALIGNMENT: To align the new variable ""harmonization unit for site"" with the existing variable ""UNIT,"" you should ensure that the definition and purpose of the harmonization unit align with the concept of a specific unit of measurement or observation within a study. Consider standardizing the definition and usage of the harmonization unit to match the existing variable ""UNIT"" in the data repository. This will help maintain consistency and facilitate data harmonization efforts.']",
unit_geographic_site,"harmonization unit for site (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNIT,242992,0.9775,,
unit_geographic_site,"harmonization unit for site (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.96909106,,
cardiac_output,RV Cardiac output (l/min) (HARMONIZED),RV CARDIAC OUTPUT (ML/MIN),205079,0.9860443,"['1. RV CARDIAC OUTPUT (ML/MIN) - This variable represents the right ventricular cardiac output in milliliters per minute. It specifically focuses on the output from the right side of the heart.', '', '2. CARDIAC OUTPUT (L/MIN) - This variable represents the overall cardiac output in liters per minute, which includes the combined output from both the left and right sides of the heart.', '', ""3. MEASURED CARDIAC OUTPUT (L/MIN) - This variable represents the measured cardiac output in liters per minute, providing a general measurement of the heart's pumping ability."", '', 'SELECTED: CARDIAC OUTPUT (L/MIN)', 'ALIGNMENT: To align the new variable ""RV Cardiac output (l/min)"" with the selected existing variable ""CARDIAC OUTPUT (L/MIN)"", you will need to ensure that the measurement units are consistent (both in liters per minute) and that the focus is on the overall cardiac output rather than specifically on the right ventricular output. This alignment will help in harmonizing the new variable with the existing variable in the data repository.']",
cardiac_output,RV Cardiac output (l/min) (HARMONIZED),CARDIAC OUTPUT (L/MIN),42413,0.7856377,,
cardiac_output,RV Cardiac output (l/min) (HARMONIZED),MEASURED CARDIAC OUTPUT (L/MIN),144968,0.7412996,,
age_at_bmi_baseline,age at measurement of bmi (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.40574303,"['Existing Variables:', ""1. AGE AT MEASUREMENT - This variable captures the age at which a particular measurement was taken. It provides context on the individual's age at the time of assessment."", ""2. ADULT 1 BMI AT YEAR 1 - This variable represents the Body Mass Index (BMI) of an adult individual at the first year of assessment. It gives insight into the individual's BMI at a specific time point."", '3. ADULT 4 BMI AT YEAR 1 - Similar to the previous variable, this represents the BMI of an adult individual at the first year of assessment, but from a different study or dataset.', '', 'SELECTED: AGE AT MEASUREMENT', 'ALIGNMENT: To align the new variable ""age at measurement of bmi (years)"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the age recorded for the BMI measurement corresponds to the age at which the measurement was taken. This will help maintain consistency and relevance in the dataset. Additionally, consider standardizing the format of the age variable to ensure uniformity across all records.']",
age_at_bmi_baseline,age at measurement of bmi (years) (HARMONIZED),ADULT 1 BMI AT YEAR 1,14898,0.28150436,,
age_at_bmi_baseline,age at measurement of bmi (years) (HARMONIZED),ADULT 4 BMI AT YEAR 1,15157,0.25219983,,
age_at_height_baseline,age at measurement of height_baseline (years) (HARMONIZED),AGE AT BASELINE (YEARS),16530,0.7701192,"['Existing Variables:', '1. AGE AT BASELINE (YEARS) - This variable captures the age of the participants at the baseline of the study, providing a reference point for their age throughout the study.', '2. STANDARDIZED AGE AT BASELINE - This variable may have been adjusted or standardized in some way to account for potential confounding factors or to make comparisons across different studies more straightforward.', '3. AGE AT BASELINE - This variable is similar to the first one, capturing the age of the participants at the baseline of the study.', '', 'SELECTED: AGE AT BASELINE', 'ALIGNMENT: To align the new variable ""age at measurement of height_baseline (years)"" with the selected existing variable ""AGE AT BASELINE,"" ensure that the measurement of age at the baseline of the study is consistent and accurately reflects the age of the participants at that time point. This will help maintain the integrity and consistency of the age variable in the data repository.']",
age_at_height_baseline,age at measurement of height_baseline (years) (HARMONIZED),STANDARDIZED AGE AT BASELINE,222980,0.744842,,
age_at_height_baseline,age at measurement of height_baseline (years) (HARMONIZED),AGE AT BASELINE,16529,0.68130285,,
age_at_index,"The subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED). If age is greater than 89 years, see 'age_at_index_gt89'.",SUBJECT AGE,226270,0.41472104,"['Existing Variables:', ""1. SUBJECT AGE - This variable likely captures the age of the subject at a specific point in time, which aligns with the concept of the subject's age on a reference or anchor date."", ""2. AGE OF SUBJECT - This variable also captures the age of the subject, which is relevant to the new variable describing the subject's age on a specific date."", '3. AGE; AGE >89 CATEGORIZED AS "">89"" - This variable categorizes subjects aged over 89, which could be relevant if the new variable requires special handling for subjects over a certain age.', '', 'SELECTED: SUBJECT AGE', 'ALIGNMENT: To align the new variable with the existing variable ""SUBJECT AGE,"" ensure that the new variable captures the subject\'s age in years on the specific reference or anchor date used during date obfuscation. If the subject\'s age is greater than 89 years, consider how this information can be integrated or categorized accordingly.']",
age_at_index,"The subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED). If age is greater than 89 years, see 'age_at_index_gt89'.",AGE OF SUBJECT,17285,0.40374315,,
age_at_index,"The subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED). If age is greater than 89 years, see 'age_at_index_gt89'.","AGE; AGE >89 CATEGORIZED AS "">89""",17616,0.13028543,,
age_at_index_gt89,Indicate whether the subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED) is greater than 89 years.,"AGE; AGE >89 CATEGORIZED AS "">89""",17616,0.8472108,"['1. AGE (YEARS) - This existing variable directly relates to the new variable as both involve age in years. The existing variable provides a clear understanding of how age is categorized based on years.', '2. AGE - This existing variable also relates to the new variable as it involves age. However, it lacks the specificity of categorizing age based on years as in the first existing variable.', '3. GENDER - This existing variable is not directly relevant to the new variable as it pertains to gender rather than age.', '', 'SELECTED: AGE (YEARS)', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the age data collected for the new variable is in years and follows the same categorization as the existing variable (e.g., <18, >88). This will help harmonize the new variable with the existing age variable in the repository.']",
age_at_index_gt89,Indicate whether the subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED) is greater than 89 years.,IS TRUE AGE GREATER THAN 89?,128269,0.55223787,,
age_at_index_gt89,Indicate whether the subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED) is greater than 89 years.,"AGE (YEARS) 17 = <18, 89 = >88",16399,0.263789,,
age_at_weight_baseline,age at measurement of weight_baseline (years) (HARMONIZED),AGE AT BASELINE (YEARS),16530,0.661595,"['Existing Variables:', '1. AGE AT BASELINE (YEARS) - This variable captures the age of the participants at the baseline of the study, providing a reference point for their age throughout the study.', '2. STANDARDIZED AGE AT BASELINE - This variable may have been adjusted or standardized to account for any variations or inconsistencies in age reporting across different studies or datasets.', '3. AGE AT BASELINE - This variable is similar to the first one, capturing the age of the participants at the baseline of the study.', '', 'SELECTED: AGE AT BASELINE (YEARS)', 'ALIGNMENT: To align the new variable ""age at measurement of weight_baseline (years)"" with the selected existing variable ""AGE AT BASELINE (YEARS)"", ensure that the measurement of age at the time of weight_baseline is consistent with the baseline age captured in the existing variable. This may involve verifying that the time point of weight_baseline aligns with the baseline of the study and that the age measurement is in years. Additionally, consider any adjustments or standardization needed to harmonize the new variable with the existing variable.']",
age_at_weight_baseline,age at measurement of weight_baseline (years) (HARMONIZED),STANDARDIZED AGE AT BASELINE,222980,0.6438893,,
age_at_weight_baseline,age at measurement of weight_baseline (years) (HARMONIZED),AGE AT BASELINE,16529,0.5809465,,
annotated_sex,"Subject sex, as recorded by the study. (HARMONIZED)",SEX OF SUBJECT,211860,0.8147908,"['Existing Variables:', '1. SEX OF SUBJECT - This variable captures the sex of the subjects in the study.', '2. SUBJECTS SEX - This variable also captures the sex of the subjects in the study.', '3. GENDER (RECORDED AND USED BY BLOCK) - This variable records the gender of the subjects as recorded and used by block.', '', 'SELECTED: SEX OF SUBJECT', 'ALIGNMENT: To align the new variable ""Subject sex, as recorded by the study"" with the existing variable ""SEX OF SUBJECT"", ensure that the data entry for the new variable follows the same format and categories as the existing variable. This will help maintain consistency and facilitate data analysis across different studies in the repository.']",
annotated_sex,"Subject sex, as recorded by the study. (HARMONIZED)",SUBJECTS SEX,226588,0.7243831,,
annotated_sex,"Subject sex, as recorded by the study. (HARMONIZED)",GENDER (RECORDED AND USED BY BLOCK),103087,0.15190639,,
bmi_baseline,Body mass index calculated at baseline. (kg/m^2) (HARMONIZED),BODY MASS INDEX AT BASELINE,35519,0.9860443,"['Existing Variables:', ""1. BODY MASS INDEX AT BASELINE - This variable captures the body mass index measurement at baseline, providing information on the individual's weight status at the beginning of the study."", '2. BASELINE BODY MASS INDEX (KG/M SQRD) - This variable specifically indicates the baseline body mass index measurement in units of kg/m squared, which is a common way to express BMI.', '3. BODY MASS INDEX (KG/M^2) - This variable represents the body mass index measurement in kg/m^2, which is a standard unit for BMI calculations.', '', 'SELECTED: BODY MASS INDEX (KG/M^2)', 'ALIGNMENT: To align the new variable ""Body mass index calculated at baseline (kg/m^2)"" with the selected existing variable ""BODY MASS INDEX (KG/M^2)"", ensure that the calculation method and units for BMI are consistent with the existing variable. Use the formula BMI = weight (kg) / height^2 (m^2) to calculate the BMI at baseline and store the values in kg/m^2 format for harmonization with the existing variable. Additionally, ensure that the measurement technique and data collection procedures for BMI are standardized to maintain data integrity and comparability within the repository.']",
bmi_baseline,Body mass index calculated at baseline. (kg/m^2) (HARMONIZED),BASELINE BODY MASS INDEX (KG/M SQRD),31003,0.9757161,,
bmi_baseline,Body mass index calculated at baseline. (kg/m^2) (HARMONIZED),BODY MASS INDEX (KG/M^2),35505,0.89805347,,
ethnicity,"An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino (HARMONIZED). The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.",ETHNICITY - HISPANIC OR LATINO,83708,0.37616467,"['Existing Variables:', '1. ETHNICITY - HISPANIC OR LATINO', '2. ETHNICITY (HISPANIC OR LATINO)', '3. RACE/ETHNICITY: HISPANIC OR LATINO', '', 'SELECTED: ETHNICITY - HISPANIC OR LATINO', 'ALIGNMENT: To align the new variable with the existing variable ""ETHNICITY - HISPANIC OR LATINO,"" ensure that the categories and definitions for self-described social and cultural grouping as Hispanic or Latino match those used in the existing variable. This may involve mapping the values provided in the new variable to the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau as done in the existing variable. Additionally, consider any additional metadata or documentation associated with the existing variable to ensure accurate alignment.']",
ethnicity,"An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino (HARMONIZED). The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.",ETHNICITY (HISPANIC OR LATINO),83705,0.34886694,,
ethnicity,"An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino (HARMONIZED). The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.",RACE/ETHNICITY: HISPANIC OR LATINO,193982,0.2979804,,
height_baseline,Body height at baseline. (cm) (HARMONIZED),BASELINE HEIGHT (CM),31275,0.9514138,"['Existing Variables:', '1. BASELINE HEIGHT (CM) - This variable represents the height of an individual at the baseline measurement.', '2. ADULT 1 HEIGHT (CM) AT BASELINE - This variable specifically denotes the height of an adult individual at the baseline measurement.', '3. ADULT 2 HEIGHT (CM) AT BASELINE - Similar to the previous variable, this represents the height of another adult individual at the baseline measurement.', '', 'SELECTED: BASELINE HEIGHT (CM)', 'ALIGNMENT: To align the new variable ""Body height at baseline (cm)"" with the selected existing variable ""BASELINE HEIGHT (CM)"", ensure that the measurement units are consistent (cm) and that the timing of the measurement corresponds to the baseline assessment in the dataset. Additionally, consider any specific age or population criteria that may apply to the existing variable for accurate harmonization.']",
height_baseline,Body height at baseline. (cm) (HARMONIZED),ADULT 1 HEIGHT (CM) AT BASELINE,14907,0.9449947,,
height_baseline,Body height at baseline. (cm) (HARMONIZED),ADULT 2 HEIGHT (CM) AT BASELINE,15021,0.9269676,,
hispanic_subgroup,classification of Hispanic/Latino background for Hispanic/Latino subjects where country or region of origin information is available (HARMONIZED),7-LEVEL RE-CLASSIFICATION OF HISPANIC/LATINO BACKGROUND,10011,0.88059187,"['1. 7-LEVEL RE-CLASSIFICATION OF HISPANIC/LATINO BACKGROUND - This existing variable provides a detailed classification of Hispanic/Latino background, which can be useful for categorizing subjects based on their background.', '', '2. CROSS-CLASSIFICATION OF CENTER AND HISPANIC/LATINO BACKGROUND - This existing variable combines information on the center where the data was collected with the Hispanic/Latino background of the subjects. It can help in analyzing the distribution of Hispanic/Latino subjects across different centers.', '', '3. CROSS-CLASSIFICATION OF CENTER AND HISPANIC LATINO BACKGROUND, 45+ YEARS ONLY - This existing variable further refines the cross-classification by focusing on subjects who are 45 years old and above. It can be valuable for studying the characteristics of older Hispanic/Latino individuals in different centers.', '', 'SELECTED: 7-LEVEL RE-CLASSIFICATION OF HISPANIC/LATINO BACKGROUND', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the classification of Hispanic/Latino background for subjects includes detailed information that can be categorized into the 7-level classification provided in the existing variable. Make sure to harmonize the new variable with the same categories and definitions used in the 7-level re-classification for consistency in data analysis.']",
hispanic_subgroup,classification of Hispanic/Latino background for Hispanic/Latino subjects where country or region of origin information is available (HARMONIZED),CROSS-CLASSIFICATION OF CENTER AND HISPANIC/LATINO BACKGROUND,55433,0.7164171,,
hispanic_subgroup,classification of Hispanic/Latino background for Hispanic/Latino subjects where country or region of origin information is available (HARMONIZED),"CROSS-CLASSIFICATION OF CENTER AND HISPANIC LATINO BACKGROUND, 45+ YEARS ONLY",55432,0.5832627,,
population,"CHB Han Chinese in Beijing, China EAS; JPT Japanese in Tokyo, Japan EAS; CHS Southern Han Chinese EAS; CDX Chinese Dai in Xishuangbanna, China EAS; KHV Kinh in Ho Chi Minh City, Vietnam EAS; CEU Utah Residents (CEPH) with Northern and Western European Ancestry EUR; TSI Toscani in Italia EUR; FIN Finnish in Finland EUR; GBR British in England and Scotland EUR; IBS Iberian Population in Spain EUR; YRI Yoruba in Ibadan, Nigeria AFR; LWK Luhya in Webuye, Kenya AFR; GWD Gambian in Western Divisions in the Gambia AFR; MSL Mende in Sierra Leone AFR; ESN Esan in Nigeria AFR; ASW Americans of African Ancestry in SW USA AFR; ACB African Caribbeans in Barbados AFR; MXL Mexican Ancestry from Los Angeles USA AMR; PUR Puerto Ricans from Puerto Rico AMR; CLM Colombians from Medellin, Colombia AMR; PEL Peruvians from Lima, Peru AMR; GIH Gujarati Indian from Houston, Texas SAS; PJL Punjabi from Lahore, Pakistan SAS; BEB Bengali from Bangladesh SAS; STU Sri Lankan Tamil from the UK SAS; ITU Indian Telugu from the UK","RACE/ETHNICITY: ASIAN, NAT AM SET TO OTHER (6)",193981,0.9652504,"['1. RACE/ETHNICITY: ASIAN - This existing variable is relevant to the new variable as it includes specific ethnicities such as Han Chinese, Japanese, and Southern Han Chinese, which are similar to the CHB, JPT, and CHS populations in the new variable.', ""2. RACE/ETHNICITY: ASIAN - This existing variable is also relevant as it includes Asian populations, which align with the new variable's populations from China and Japan."", '3. PRE-HOSPITAL RACE/ETHNICITY: ASIAN - This existing variable is relevant as it specifies Asian populations, similar to the populations included in the new variable.', '', 'SELECTED: RACE/ETHNICITY: ASIAN', 'ALIGNMENT: To align the new variable with the existing variable ""RACE/ETHNICITY: ASIAN,"" ensure that the categories and populations in the new variable (e.g., CHB Han Chinese, JPT Japanese, CHS Southern Han Chinese) are mapped or grouped under the broader category of ""Asian"" in the existing variable. This alignment will help harmonize the new variable with the existing variable in the data repository.']",
population,"CHB Han Chinese in Beijing, China EAS; JPT Japanese in Tokyo, Japan EAS; CHS Southern Han Chinese EAS; CDX Chinese Dai in Xishuangbanna, China EAS; KHV Kinh in Ho Chi Minh City, Vietnam EAS; CEU Utah Residents (CEPH) with Northern and Western European Ancestry EUR; TSI Toscani in Italia EUR; FIN Finnish in Finland EUR; GBR British in England and Scotland EUR; IBS Iberian Population in Spain EUR; YRI Yoruba in Ibadan, Nigeria AFR; LWK Luhya in Webuye, Kenya AFR; GWD Gambian in Western Divisions in the Gambia AFR; MSL Mende in Sierra Leone AFR; ESN Esan in Nigeria AFR; ASW Americans of African Ancestry in SW USA AFR; ACB African Caribbeans in Barbados AFR; MXL Mexican Ancestry from Los Angeles USA AMR; PUR Puerto Ricans from Puerto Rico AMR; CLM Colombians from Medellin, Colombia AMR; PEL Peruvians from Lima, Peru AMR; GIH Gujarati Indian from Houston, Texas SAS; PJL Punjabi from Lahore, Pakistan SAS; BEB Bengali from Bangladesh SAS; STU Sri Lankan Tamil from the UK SAS; ITU Indian Telugu from the UK",RACE/ETHNICITY: ASIAN,193980,0.9652504,,
population,"CHB Han Chinese in Beijing, China EAS; JPT Japanese in Tokyo, Japan EAS; CHS Southern Han Chinese EAS; CDX Chinese Dai in Xishuangbanna, China EAS; KHV Kinh in Ho Chi Minh City, Vietnam EAS; CEU Utah Residents (CEPH) with Northern and Western European Ancestry EUR; TSI Toscani in Italia EUR; FIN Finnish in Finland EUR; GBR British in England and Scotland EUR; IBS Iberian Population in Spain EUR; YRI Yoruba in Ibadan, Nigeria AFR; LWK Luhya in Webuye, Kenya AFR; GWD Gambian in Western Divisions in the Gambia AFR; MSL Mende in Sierra Leone AFR; ESN Esan in Nigeria AFR; ASW Americans of African Ancestry in SW USA AFR; ACB African Caribbeans in Barbados AFR; MXL Mexican Ancestry from Los Angeles USA AMR; PUR Puerto Ricans from Puerto Rico AMR; CLM Colombians from Medellin, Colombia AMR; PEL Peruvians from Lima, Peru AMR; GIH Gujarati Indian from Houston, Texas SAS; PJL Punjabi from Lahore, Pakistan SAS; BEB Bengali from Bangladesh SAS; STU Sri Lankan Tamil from the UK SAS; ITU Indian Telugu from the UK",PRE-HOSPITAL RACE/ETHNICITY: ASIAN,185451,0.95687664,,
race,"Harmonized race category of participant. Acceptable values: white,american indian or alaska native,black or african american,asian,native hawaiian or other pacific islander,hispanic,multiple,other,Unknown,not reported,not allowed to collect (HARMONIZED)",PARTICIPANT'S RACE (1=HISPANIC 2=ASIAN/PACIFIC ISLANDER 3=AFRICAN AMERICAN 4=CAUCASIAN 5=OTHER),177240,0.82290184,"['Existing Variables:', ""1. PARTICIPANT'S RACE (1=HISPANIC 2=ASIAN/PACIFIC ISLANDER 3=AFRICAN AMERICAN 4=CAUCASIAN 5=OTHER) - This variable categorizes participants based on their race, including Hispanic, Asian/Pacific Islander, African American, Caucasian, and Other."", ""2. RACE: AMERICAN INDIAN/ALASKAN NATIVE, ASIAN, OR NATIVE HAWAI'IAN/OTHER PACIFIC ISLANDER - This variable further breaks down race categories into American Indian/Alaskan Native, Asian, and Native Hawai'ian/Other Pacific Islander."", '3. RACE (1 WHITE, 2 BLACK, 3 AMER INDIAN/ALASKAN NATIVE, 4 ASIAN/PACIFIC ISLANDER) - Similar to the first two variables, this variable categorizes race into White, Black, American Indian/Alaskan Native, and Asian/Pacific Islander.', '', ""SELECTED: PARTICIPANT'S RACE"", 'ALIGNMENT: To align the new variable ""Harmonized race category of participant"" with the selected existing variable ""PARTICIPANT\'S RACE,"" you can map the acceptable values as follows:', '- White: 4 (Caucasian)', '- American Indian or Alaska Native: 3 (American Indian/Alaskan Native)', '- Black or African American: 2 (African American)', '- Asian: 2 (Asian/Pacific Islander)', '- Native Hawaiian or Other Pacific Islander: 2 (Asian/Pacific Islander)', '- Hispanic: 1 (Hispanic)', '- Multiple: 5 (Other)', '- Other: 5 (Other)', '- Unknown: 5 (Other)', '- Not reported: 5 (Other)', '- Not allowed to collect: 5 (Other)']",
race,"Harmonized race category of participant. Acceptable values: white,american indian or alaska native,black or african american,asian,native hawaiian or other pacific islander,hispanic,multiple,other,Unknown,not reported,not allowed to collect (HARMONIZED)","RACE: AMERICAN INDIAN/ALASKAN NATIVE, ASIAN, OR NATIVE HAWAI'IAN/OTHER PACIFIC ISLANDER",193999,0.4029206,,
race,"Harmonized race category of participant. Acceptable values: white,american indian or alaska native,black or african american,asian,native hawaiian or other pacific islander,hispanic,multiple,other,Unknown,not reported,not allowed to collect (HARMONIZED)","RACE (1 WHITE, 2 BLACK, 3 AMER INDIAN/ALASKAN NATIVE, 4 ASIAN/PACIFIC ISLANDER)",193818,0.38856003,,
subcohort,"A distinct subgroup within a study, generally indicating subjects who share similar characteristics due to study design. Subjects may belong to only one subcohort. (HARMONIZED)",SUB-COHORT GROUP,226135,0.9468921,"['Existing Variables:', '1. SUB-COHORT GROUP - This variable likely represents a specific group within a larger cohort that shares similar characteristics or have been grouped together for a particular reason. It could be used to categorize subjects based on certain criteria.', '2. SUBGROUP - This variable may also represent a subgroup within a larger population or cohort. It could be used to identify subjects with common characteristics or traits.', '3. STUDY COHORT - This variable likely represents the overall group of subjects included in a particular study or research project. It could be used to differentiate between different studies or projects within the repository.', '', 'SELECTED: SUB-COHORT GROUP', 'ALIGNMENT: To align your new variable with the existing variable ""SUB-COHORT GROUP,"" you should ensure that your new variable clearly defines a distinct subgroup within a study population. Consider specifying the criteria used to define this subgroup and how it relates to the overall study design. Additionally, make sure that subjects are only assigned to one subcohort to maintain consistency with the existing variable. ', '', 'By aligning your new variable with ""SUB-COHORT GROUP,"" you can ensure that it fits seamlessly into the existing data repository and can be easily compared and analyzed with other variables in the dataset.']",
subcohort,"A distinct subgroup within a study, generally indicating subjects who share similar characteristics due to study design. Subjects may belong to only one subcohort. (HARMONIZED)",SUBGROUP,226252,0.82544905,,
subcohort,"A distinct subgroup within a study, generally indicating subjects who share similar characteristics due to study design. Subjects may belong to only one subcohort. (HARMONIZED)",STUDY COHORT,225347,0.761893,,
unit_annotated_sex,"harmonization unit for annotated_sex (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.9743373,"['1. OBSERVATION UNIT - The existing variable ""OBSERVATION UNIT"" refers to the unit of analysis or the entity being observed in a study. It is relevant to the new variable as it helps define the scope and context in which the harmonization unit for annotated_sex will be applied.', '', '2. PHENOTYPE - The existing variable ""PHENOTYPE"" describes the observable physical or biochemical characteristics of an individual resulting from the interaction of its genotype with the environment. It is relevant to the new variable as it provides information on the characteristics that will be used to define the harmonization unit for annotated_sex.', '', '3. UNITS - The existing variable ""UNITS"" typically refers to the units of measurement used for a particular variable. While not directly related to the concept of harmonization unit, it is important for ensuring consistency in how data is collected and reported.', '', 'SELECTED: PHENOTYPE', 'ALIGNMENT: To align the new variable ""harmonization unit for annotated_sex"" with the existing variable ""PHENOTYPE,"" researchers should consider defining the harmonization unit based on observable physical or biochemical characteristics that can be used to group subjects with similar phenotypes. This alignment will help ensure that the harmonization unit is meaningful and relevant in the context of the study data.']",
unit_annotated_sex,"harmonization unit for annotated_sex (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PHENOTYPE,181522,0.96544635,,
unit_annotated_sex,"harmonization unit for annotated_sex (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.9649213,,
unit_bmi_baseline,"harmonization unit for bmi_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",BASELINE BODY MASS INDEX,31001,0.9904406,"['Existing Variables:', '1. BASELINE BODY MASS INDEX - This variable represents the body mass index of subjects at baseline, which is a commonly used measure of body fat based on height and weight.', '2. BMI (COMPUTED BY SC FROM METRIC UNITS) (FROM ANT02,ANT03) AT BASELINE - This variable specifically indicates the BMI computed using metric units at baseline.', '3. BMI (COMPUTED BY SC FROM IMPERIAL UNITS) (FROM IEC05A,B AT BASELINE) - This variable represents the BMI computed using imperial units at baseline.', '', 'SELECTED: BASELINE BODY MASS INDEX', 'ALIGNMENT: To align the new variable ""harmonization unit for bmi_baseline"" with the existing variable ""BASELINE BODY MASS INDEX"", ensure that the harmonization unit captures the BMI values of subjects at baseline in a similar manner as the existing variable. This may involve using the same calculation method and units to ensure consistency in the data. Additionally, make sure that the defined group of subjects within the harmonization unit aligns with the subjects for whom the baseline BMI data is available. ', '', 'By selecting the existing variable ""BASELINE BODY MASS INDEX"", you can harmonize the new variable effectively by following the same measurement standards and ensuring that the subjects included in the harmonization unit match those for whom baseline BMI data is recorded.']",
unit_bmi_baseline,"harmonization unit for bmi_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)","BMI (COMPUTED BY SC FROM METRIC UNITS) (FROM ANT02,ANT03) AT BASELINE",35268,0.9886244,,
unit_bmi_baseline,"harmonization unit for bmi_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)","BMI (COMPUTED BY SC FROM IMPERIAL UNITS) (FROM IEC05A,B AT BASELINE)",35264,0.98761624,,
unit_ethnicity,"harmonization unit for ethnicity (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.9829547,"['Existing Variables:', '1. OBSERVATION UNIT - This variable identifies the unit of observation in the dataset, such as individual subjects or samples. It helps to organize and structure the data based on the entities being studied.', '2. UNITS - This variable specifies the units of measurement for quantitative variables in the dataset. It ensures consistency and accuracy in interpreting the numerical values.', '3. HOMOGENEITY - This variable indicates the degree of similarity or uniformity among the subjects or samples in the dataset. It is important for ensuring the reliability and validity of the data analysis.', '', 'SELECTED: OBSERVATION UNIT', 'ALIGNMENT: To align the new variable ""harmonization unit for ethnicity"" with the selected existing variable ""observation unit,"" you can define the harmonization unit as a specific group of subjects or samples within the dataset based on their ethnicity. This will help in organizing and structuring the data according to the defined groups, allowing for easier comparison and analysis. Additionally, you can use the observation unit variable to link the harmonization unit with other relevant variables in the dataset for comprehensive analysis.']",
unit_ethnicity,"harmonization unit for ethnicity (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.9824231,,
unit_ethnicity,"harmonization unit for ethnicity (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",2.F HOMOGENEITY,6683,0.98076576,,
unit_height_baseline,"harmonization unit for height_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEIGHTUNIT,110384,0.9759464,"['Existing Variables:', '1. HEIGHT - This variable represents the height of an individual in a specific unit of measurement.', '2. HEIGHTUNIT - This variable specifies the unit of measurement used for the height data.', '3. HARMONIZED - This variable indicates a harmonization unit for height data, which groups subjects with similar phenotypes for processing.', '', 'SELECTED: HEIGHT', 'ALIGNMENT: To align the new variable ""harmonization unit for height_baseline"" with the existing variable ""HEIGHT,"" ensure that the harmonization unit is consistent with the unit of measurement used for height data. This will help maintain uniformity and compatibility within the data repository.']",
unit_height_baseline,"harmonization unit for height_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEIGHT (UNIT),110222,0.9743861,,
unit_height_baseline,"harmonization unit for height_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNIT OF MEASUREMENT,243002,0.92749476,,
unit_hispanic_subgroup,"harmonization unit for hispanic_subgroup (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HISPANIC ETHNICITY,112232,0.9947187,"['1. HISPANIC - This existing variable captures the Hispanic ethnicity of individuals in the dataset. It is relevant to the new variable as it also pertains to Hispanic subgroup information.', '', '2. HISPANIC ETHNICITY - This existing variable provides a broader category for ethnicity, including Hispanic individuals. It may be relevant to the new variable as it encompasses the overall ethnicity information.', '', '3. UNITS - This existing variable likely refers to the units of measurement for certain variables in the dataset. It may not be directly related to the new variable on Hispanic subgroup information.', '', 'SELECTED: HISPANIC', 'ALIGNMENT: To align the new variable on harmonization unit for Hispanic subgroup with the existing variable HISPANIC, you can ensure that the subgroup information is captured consistently with the broader Hispanic ethnicity category. This may involve mapping specific subgroups to the overarching Hispanic category and ensuring that the data is harmonized across these variables.']",
unit_hispanic_subgroup,"harmonization unit for hispanic_subgroup (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HISPANIC,112230,0.9935369,,
unit_hispanic_subgroup,"harmonization unit for hispanic_subgroup (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.9658352,,
unit_race,"harmonization unit for race (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",RACE (RECODED TO HARMONIZE RESPONSES ACROSS CENTERS),193857,0.9980657,"['Existing Variables:', '1. SUBJECT RACE - This variable captures the race of the subjects in the study.', '2. OBSERVATION UNIT - This variable identifies the unit of observation in the study.', '3. RACE (RECODED TO HARMONIZE RESPONSES ACROSS CENTERS) - This variable indicates the recoded race data to ensure consistency across different centers.', '', 'SELECTED: SUBJECT RACE', 'ALIGNMENT: To align the new variable ""harmonization unit for race"" with the existing variable ""SUBJECT RACE,"" you can use the same categories and coding scheme for race. Ensure that the harmonization unit is capturing the race of the subjects in a consistent manner as the ""SUBJECT RACE"" variable. This will help in harmonizing the new variable with the existing data in the repository.']",
unit_race,"harmonization unit for race (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",SUBJECT RACE,226484,0.9955316,,
unit_race,"harmonization unit for race (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.98609793,,
unit_subcohort,"harmonization unit for subcohort (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",SUB-COHORT GROUP,226135,0.9991639,"['Existing Variables:', '1. SUB-COHORT GROUP - This variable identifies a specific subgroup within a larger cohort of subjects. It helps in categorizing subjects based on certain criteria.', '2. COHORT - This variable represents the overall group of subjects being studied. It provides a broader context for the data collected.', '3. UNITS - This variable specifies the units of measurement for a particular variable, ensuring consistency in data interpretation.', '', 'SELECTED: SUB-COHORT GROUP', 'ALIGNMENT: To align the new variable ""harmonization unit for subcohort"" with the existing variable ""SUB-COHORT GROUP,"" you should ensure that the defined groups of subjects for harmonization are similar to those identified in the ""SUB-COHORT GROUP"" variable. This will help in organizing and processing the phenotypic data in a consistent manner within the specified subgroups. Additionally, you may need to establish clear criteria for grouping subjects into harmonization units to maintain uniformity and comparability across different datasets.']",
unit_subcohort,"harmonization unit for subcohort (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",COHORT,50402,0.99455196,,
unit_subcohort,"harmonization unit for subcohort (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.98747206,,
unit_weight_baseline,"harmonization unit for weight_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WEIGHT (UNIT),253457,0.97354424,"['Existing Variables:', '1. WEIGHT (UNIT) - This variable represents the weight of an individual in the dataset, typically measured in pounds or kilograms. It is a common anthropometric measurement used in various studies.', '2. WEIGHT UNITS - This variable specifies the units in which weight is measured, such as pounds or kilograms. It helps ensure consistency in reporting weights across different studies.', '3. OBSERVATION UNIT - This variable indicates the unit of observation for each data point, which could be an individual, a group, or a specific time point. It helps in organizing and analyzing the data effectively.', '', 'SELECTED: WEIGHT (UNIT)', 'ALIGNMENT: To align the new variable ""harmonization unit for weight_baseline"" with the selected existing variable ""WEIGHT (UNIT)"", ensure that the harmonization unit for weight_baseline is measured in the same units (e.g., pounds or kilograms) as the existing weight variable. This will help maintain consistency and facilitate comparisons between the two variables. Additionally, consider standardizing the measurement protocols and procedures for collecting weight data to further harmonize the variables.']",
unit_weight_baseline,"harmonization unit for weight_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WEIGHT UNITS,253773,0.95799094,,
unit_weight_baseline,"harmonization unit for weight_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.9222025,,
weight,Body weight at baseline. (kg) (HARMONIZED).,WEIGHT (KG) AT BASELINE,253391,0.96628344,"['Existing Variables:', '1. WEIGHT (KG) AT BASELINE - This variable captures the weight of the individual at baseline in kilograms.', '2. WEIGHT AT BASELINE (KG) - Similar to the first variable, this captures the weight of the individual at baseline in kilograms.', '3. BASELINE WEIGHT (KG) - This variable also represents the weight of the individual at baseline in kilograms.', '', 'SELECTED: WEIGHT AT BASELINE (KG)', 'ALIGNMENT: To align the new variable ""Body weight at baseline. (kg) (HARMONIZED)"" with the selected existing variable ""WEIGHT AT BASELINE (KG)"", ensure that the measurement unit is consistent (kg) and that the timing of the measurement is at baseline. Make sure to capture the weight of the individual accurately and in the same unit as the existing variable for harmonization.']",
weight,Body weight at baseline. (kg) (HARMONIZED).,WEIGHT AT BASELINE (KG),253501,0.961678,,
weight,Body weight at baseline. (kg) (HARMONIZED).,BASELINE WEIGHT (KG),31737,0.9431385,,
weight_baseline,Body weight at baseline. (kg) (HARMONIZED),WEIGHT (KG) AT BASELINE,253391,0.9719925,"['Existing Variables:', '1. WEIGHT (KG) AT BASELINE - This variable represents the weight of the individual in kilograms at the baseline of the study.', '2. WEIGHT AT BASELINE (KG) - Similar to the first variable, this represents the weight of the individual in kilograms at the baseline of the study.', '3. BASELINE WEIGHT (KG) - This variable also represents the weight of the individual in kilograms at the baseline of the study.', '', 'SELECTED: WEIGHT AT BASELINE (KG)', 'ALIGNMENT: To align the new variable ""Body weight at baseline. (kg)"" with the selected existing variable ""WEIGHT AT BASELINE (KG)"", ensure that the measurement unit is consistent (kg) and that the timing of the measurement is at the baseline of the study. Make sure to follow the same format and naming convention to harmonize the new variable with the existing variable.']",
weight_baseline,Body weight at baseline. (kg) (HARMONIZED),WEIGHT AT BASELINE (KG),253501,0.9644556,,
weight_baseline,Body weight at baseline. (kg) (HARMONIZED),BASELINE WEIGHT (KG),31737,0.95022655,,
age_at_basophil_ncnc_bld,age at measurement of basophil_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.15291561,"['Existing Variables:', '1. AGE AT MEASUREMENT - This variable represents the age at which a particular measurement was taken in the study.', '2. AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25) - This variable seems to be a calculated age at measurement, possibly adjusted for specific study parameters.', '3. AGE AT BASELINE (YEARS) - This variable indicates the age of the participant at the beginning of the study.', '', 'SELECTED: AGE AT MEASUREMENT', 'ALIGNMENT: To align the new variable ""age at measurement of basophil_ncnc_bld (years)"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the age recorded for the measurement of basophil_ncnc_bld aligns with the age at which the measurement was taken in the study. This will help maintain consistency and harmonization with the existing data in the repository.']",
age_at_basophil_ncnc_bld,age at measurement of basophil_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.07172112,,
age_at_basophil_ncnc_bld,age at measurement of basophil_ncnc_bld (years) (HARMONIZED),AGE AT BASELINE (YEARS),16530,0.05350215,,
age_at_eosinophil_ncnc_bld,age at measurement of eosinophil_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.09203286,"['Existing Variables:', '1. AGE AT MEASUREMENT - This variable captures the age at which a particular measurement was taken. It provides important context for understanding the relationship between age and other biological variables.', '2. % EOSINOPHILS - This variable represents the percentage of eosinophils in the blood. Eosinophils are a type of white blood cell involved in the immune response, and their levels can be indicative of certain health conditions.', '3. TOTAL EOSINOPHIL COUNT, CELLS/MICROLITER - This variable quantifies the total number of eosinophils present in a microliter of blood. It provides a more specific measure of eosinophil levels compared to the percentage.', '', 'SELECTED: % EOSINOPHILS', 'ALIGNMENT: To align the new variable ""age at measurement of eosinophil_ncnc_bld (years)"" with the selected existing variable ""% EOSINOPHILS"", you can consider incorporating the age at which the eosinophil count was measured into the analysis. This could involve stratifying the data by age groups or examining the relationship between age and eosinophil percentage in the blood. Additionally, you may need to standardize the age variable to ensure consistency in the analysis.']",
age_at_eosinophil_ncnc_bld,age at measurement of eosinophil_ncnc_bld (years) (HARMONIZED),9E EOSINOPHILS (%),10711,0.027117657,,
age_at_eosinophil_ncnc_bld,age at measurement of eosinophil_ncnc_bld (years) (HARMONIZED),"TOTAL EOSINOPHIL COUNT, CELLS/MICROLITER",237142,0.025468083,,
age_at_hdl,age at measurement of hdl (years) (HARMONIZED),HDL CHOLESTEROL 6 YEARS,108735,0.7077078,"['Existing Variables:', '1. HDL CHOLESTEROL (MG/DL) AT YEAR 1 - This existing variable represents the HDL cholesterol level in milligrams per deciliter at year 1. It provides a baseline measurement of HDL cholesterol.', '2. HDL CHOLESTEROL (MG/DL) AT YEAR 2 - This existing variable represents the HDL cholesterol level in milligrams per deciliter at year 2. It allows for tracking changes in HDL cholesterol over time.', '3. HDL CHOLESTEROL 6 YEARS - This existing variable represents the HDL cholesterol level after 6 years. It provides a longer-term perspective on HDL cholesterol levels.', '', 'SELECTED: HDL CHOLESTEROL (MG/DL) AT YEAR 1', 'ALIGNMENT: To align the new variable ""age at measurement of HDL (years)"" with the selected existing variable ""HDL CHOLESTEROL (MG/DL) AT YEAR 1,"" you can use the age information at the time of the first measurement of HDL cholesterol. This will allow for consistent tracking of HDL cholesterol levels at a specific time point relative to the individual\'s age.']",
age_at_hdl,age at measurement of hdl (years) (HARMONIZED),HDL CHOLESTEROL (MG/DL) AT YEAR 1,108717,0.46660253,,
age_at_hdl,age at measurement of hdl (years) (HARMONIZED),HDL CHOLESTEROL (MG/DL) AT YEAR 2,108718,0.4434799,,
age_at_hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (years) (HARMONIZED)",HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD),110470,0.87976795,"['Existing Variables:', '1. HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD) - This existing variable directly relates to the new variable as it also measures the percentage of red blood cells in whole blood.', '2. BLOOD ANALYSIS: HEMATOCRIT - This existing variable provides context that the hematocrit measurement is part of a blood analysis, which aligns with the new variable description.', '3. HEMATOCRIT (HCT %) - Another existing variable that measures hematocrit percentage, providing additional options for harmonization.', '', 'SELECTED: HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD)', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement of hematocrit is expressed as a percentage of red blood cells in whole blood. Use the same units of measurement (%), and ensure that the methodology for calculating hematocrit is consistent with the existing variable. Additionally, consider any specific guidelines or protocols related to hematocrit measurements in the data repository to ensure harmonization.']",
age_at_hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (years) (HARMONIZED)",BLOOD ANALYSIS: HEMATOCRIT,34250,0.85800624,,
age_at_hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (years) (HARMONIZED)",HEMATOCRIT (HCT %),110481,0.8458151,,
age_at_hemoglobin_mcnc_bld,age at measurement of hemoglobin_mcnc_bld. (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.16762705,"['Existing Variables:', '1. AGE AT MEASUREMENT - This variable captures the age of the individual at the time of measurement, which can be relevant for understanding how age may impact the measurement of hemoglobin levels.', '2. DAYS TO DATE OF HGB MEASUREMENT - This variable provides information on the number of days between the date of measurement and the date of the hemoglobin measurement, which could be useful for temporal analysis.', '3. AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25) - This variable calculates the age at measurement based on a specific formula, taking into account certain factors that may influence age calculation.', '', 'SELECTED: AGE AT MEASUREMENT', 'ALIGNMENT: To align the new variable ""age at measurement of hemoglobin_mcnc_bld. (years) (HARMONIZED)"" with the existing variable ""AGE AT MEASUREMENT,"" ensure that the age recorded for the hemoglobin measurement is consistent with the age recorded at the time of measurement in the dataset. This alignment will help maintain consistency in age-related analyses and interpretations.']",
age_at_hemoglobin_mcnc_bld,age at measurement of hemoglobin_mcnc_bld. (years) (HARMONIZED),DAYS TO DATE OF HGB MEASUREMENT,66283,0.12485182,,
age_at_hemoglobin_mcnc_bld,age at measurement of hemoglobin_mcnc_bld. (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.07751766,,
age_at_ldl,age at measurement of ldl (years) (HARMONIZED),LDL CHOLESTEROL 6 YEARS,131933,0.6884684,"['Existing Variables:', '1. LDL-CHOLESTEROL (DERIVED) (MG/DL) AT YEAR 3 - This variable represents the LDL cholesterol level measured in milligrams per deciliter at year 3. It is a quantitative measure of LDL cholesterol at a specific time point.', '2. LDL-CHOLESTEROL (DERIVED) (MG/DL) AT YEAR 1 - This variable represents the LDL cholesterol level measured in milligrams per deciliter at year 1. Similar to the previous variable, it is a quantitative measure of LDL cholesterol at a specific time point.', '3. LDL CHOLESTEROL 6 YEARS - This variable represents LDL cholesterol measured at 6 years. It is another quantitative measure of LDL cholesterol at a specific time point.', '', 'SELECTED: LDL-CHOLESTEROL (DERIVED) (MG/DL) AT YEAR 3', 'ALIGNMENT: To align the new variable ""age at measurement of ldl (years)"" with the selected existing variable ""LDL-CHOLESTEROL (DERIVED) (MG/DL) AT YEAR 3"", you should ensure that the age at measurement corresponds to the time point of year 3. This means that the age should be calculated based on the year of measurement for LDL cholesterol. Additionally, the unit of measurement for LDL cholesterol should be consistent with milligrams per deciliter (mg/dL) to maintain alignment with the existing variable.']",
age_at_ldl,age at measurement of ldl (years) (HARMONIZED),LDL-CHOLESTEROL (DERIVED) (MG/DL) AT YEAR 3,131973,0.53913486,,
age_at_ldl,age at measurement of ldl (years) (HARMONIZED),LDL-CHOLESTEROL (DERIVED) (MG/DL) AT YEAR 1,131971,0.48751327,,
age_at_lymphocyte_ncnc_bld,age at measurement of lymphocyte_ncnc_bld (years) (HARMONIZED),AGE AT BLOOD OR LYMPH CANCER,16534,0.035144847,"['Existing Variables:', '1. AGE AT BLOOD OR LYMPH CANCER - This variable captures the age at which an individual was diagnosed with blood or lymph cancer. It provides information on the age of the individual at a specific medical event related to blood or lymph cancer.', '2. DATE OF LYMPHOCYTE COUNT (DATE TO DAYS) - This variable records the date of the lymphocyte count measurement in days. It helps track the timing of when the lymphocyte count was taken.', '3. DAYS FROM RANDOMIZATION TO DATE OF LYMPHOCYTE COUNT - This variable measures the number of days between the randomization date and the date of the lymphocyte count. It provides a timeline for when the lymphocyte count was measured in relation to the randomization date.', '', 'SELECTED: AGE AT BLOOD OR LYMPH CANCER', 'ALIGNMENT: To align the new variable ""age at measurement of lymphocyte_ncnc_bld (years)"" with the selected existing variable ""AGE AT BLOOD OR LYMPH CANCER,"" you should ensure that the age recorded in the new variable pertains specifically to the measurement of lymphocyte count in blood. This means that the age should correspond to the time when the lymphocyte count was taken in relation to any blood or lymph cancer diagnosis or treatment. By harmonizing the new variable with the existing variable ""AGE AT BLOOD OR LYMPH CANCER,"" you can maintain consistency in capturing age-related information in the context of blood or lymph cancer.']",
age_at_lymphocyte_ncnc_bld,age at measurement of lymphocyte_ncnc_bld (years) (HARMONIZED),DATE OF LYMPHOCYTE COUNT (DATE TO DAYS),61268,0.031084951,,
age_at_lymphocyte_ncnc_bld,age at measurement of lymphocyte_ncnc_bld (years) (HARMONIZED),DAYS FROM RANDOMIZATION TO DATE OF LYMPHOCYTE COUNT,64945,0.01302049,,
age_at_mch_entmass_rbc,age at measurement of mch_entmass_rbc (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.19042274,"['Existing Variables:', '1. AGE AT MEASUREMENT - This variable captures the age of the individual at the time of measurement, which is relevant for understanding the impact of age on various biological factors.', '2. UNITS - MCHC - This variable specifies the units for Mean Corpuscular Hemoglobin Concentration (MCHC), which is a measure of the concentration of hemoglobin in a given volume of packed red blood cells.', '3. AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25) - This variable calculates the age at measurement based on specific data points in the dataset and converts it to years.', '', 'SELECTED: AGE AT MEASUREMENT', 'ALIGNMENT: To align the new variable ""age at measurement of mch_entmass_rbc (years)"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the age recorded for the measurement of MCH entmass RBC is consistent with the age at measurement captured in the dataset. This will help in harmonizing the new variable with the existing variable and maintain consistency in the dataset.']",
age_at_mch_entmass_rbc,age at measurement of mch_entmass_rbc (years) (HARMONIZED),UNITS - MCHC,243063,0.1261379,,
age_at_mch_entmass_rbc,age at measurement of mch_entmass_rbc (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.086632065,,
age_at_mchc_mcnc_rbc,age at measurement of mchc_mcnc_rbc (years) (HARMONIZED),UNITS - MCHC,243063,0.22236222,"['Existing Variables:', '1. UNITS - MCHC', '   - The existing variable ""UNITS"" may be relevant as it could provide information on the units used to measure MCHC (Mean Corpuscular Hemoglobin Concentration).', '', '2. AGE AT MEASUREMENT ((MBCA2-DSRA4)/365.25)', '   - The existing variable ""AGE AT MEASUREMENT"" could be important as it indicates the age at which the measurement was taken, which could be relevant when harmonizing the new variable related to age at measurement of MCHC.', '', '3. MCHC', '   - The existing variable ""MCHC"" is directly related to the new variable, as both involve the measurement of Mean Corpuscular Hemoglobin Concentration.', '', 'SELECTED: MCHC', 'ALIGNMENT: To align the new variable ""age at measurement of mchc_mcnc_rbc (years)"" with the existing variable ""MCHC,"" ensure that the age at measurement is recorded in years and that the measurement is specifically related to MCHC levels in red blood cells. Consistency in data collection methods and units will help harmonize the new variable with the existing variable ""MCHC.""']",
age_at_mchc_mcnc_rbc,age at measurement of mchc_mcnc_rbc (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.15752527,,
age_at_mchc_mcnc_rbc,age at measurement of mchc_mcnc_rbc (years) (HARMONIZED),MCHC,142506,0.12527926,,
age_at_mcv_entvol_rbc,age at measurement of mcv_entvol_rbc (years) (HARMONIZED),MCV,142587,0.16559312,"['Existing Variables:', '1. MCV - Mean Cell Volume (MCV) is a measure of the average volume of a red blood cell. It is an important parameter in the evaluation of anemia and other blood disorders.', '2. AGE AT MEASUREMENT ((MBCA2-DSRA4)/365.25) - This variable represents the age at which the measurement was taken, which is crucial for understanding the context of any biological parameter.', '3. MEAN CELL VOLUME (MCV) - This existing variable is the same as the new variable, which is ""age at measurement of mcv_entvol_rbc (years) (HARMONIZED).""', '', 'SELECTED: MCV', 'ALIGNMENT: To align the new variable ""age at measurement of mcv_entvol_rbc (years) (HARMONIZED)"" with the existing variable MCV, ensure that the age at which the mean cell volume measurement was taken is accurately recorded in years. This alignment will help maintain consistency and facilitate data analysis across different variables in the repository.']",
age_at_mcv_entvol_rbc,age at measurement of mcv_entvol_rbc (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.104660206,,
age_at_mcv_entvol_rbc,age at measurement of mcv_entvol_rbc (years) (HARMONIZED),MEAN CELL VOLUME (MCV),143075,0.07793769,,
age_at_monocyte_ncnc_bld,age at measurement of monocyte_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.23144047,"['Existing Variables:', '1. AGE AT MEASUREMENT - This variable represents the age at which a particular measurement was taken. It is a common demographic variable used in many studies to account for age-related differences.', '2. AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25) - This variable seems to be a calculated age at measurement, possibly adjusted for specific study parameters. It may provide a more precise age value for analysis.', '3. CD34P_AC133P_B1 PERIPHERAL BLOOD MEASURE AT BASELINE - This variable represents a specific measurement related to peripheral blood at baseline, which could be relevant depending on the nature of the new variable.', '', 'SELECTED: AGE AT MEASUREMENT', 'ALIGNMENT: To align the new variable ""age at measurement of monocyte_ncnc_bld (years)"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the age values are recorded consistently in years. If the new variable provides age in a different unit, convert it to years for harmonization. Additionally, consider any adjustments or calculations needed to match the format of the existing variable for accurate analysis and comparison.']",
age_at_monocyte_ncnc_bld,age at measurement of monocyte_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.1328517,,
age_at_monocyte_ncnc_bld,age at measurement of monocyte_ncnc_bld (years) (HARMONIZED),CD34P_AC133P_B1 PERIPHERAL BLOOD MEASURE AT BASELINE,44029,0.041230027,,
age_at_neutrophil_ncnc_bld,age at measurement of neutrophil_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.13788034,"['Existing Variables:', '1. AGE AT MEASUREMENT - This variable represents the age at which a particular measurement was taken. It is a fundamental demographic variable that can provide context to other biological measurements.', ""2. ABSOLUTE NEUTROPHIL COUNT (ANC) - ANC is a measure of the number of neutrophils in the blood, which is an important component of the immune system. It is a quantitative measure that can indicate the body's response to infection or inflammation."", '3. II_3B ABSOLUTE NEUTROPHIL COUNT (ANC) - This variable likely represents a specific type of absolute neutrophil count measurement, possibly from a different study or source.', '', 'SELECTED: ABSOLUTE NEUTROPHIL COUNT (ANC)', 'ALIGNMENT: To align the new variable ""age at measurement of neutrophil_ncnc_bld (years)"" with the selected existing variable ""ABSOLUTE NEUTROPHIL COUNT (ANC)"", you should ensure that the age at measurement corresponds to the time at which the ANC measurement was taken. This alignment will help in harmonizing the new variable with the existing variable by providing a clear link between the age of the individual and their neutrophil count in the blood.']",
age_at_neutrophil_ncnc_bld,age at measurement of neutrophil_ncnc_bld (years) (HARMONIZED),ABSOLUTE NEUTROPHIL COUNT (ANC),12042,0.0921962,,
age_at_neutrophil_ncnc_bld,age at measurement of neutrophil_ncnc_bld (years) (HARMONIZED),II_3B ABSOLUTE NEUTROPHIL COUNT (ANC),121311,0.08093671,,
age_at_platelet_ncnc_bld,age at measurement of platelet_ncnc_bld (years) (HARMONIZED),DAYS TO DATE OF PLATELETS MEASUREMENT,66303,0.29421496,"['1. DAYS TO DATE OF PLATELETS MEASUREMENT - This variable measures the number of days between the date of platelets measurement and another reference date. It may not directly align with the new variable as it focuses on the timing aspect rather than the age aspect.', '', '2. AGE (YRS) RECVD A TRANSFUSION OF PLATELE - This variable captures the age at which an individual received a platelet transfusion. While it involves platelets, it is specific to transfusions and may not be the best fit for harmonizing the new variable related to age at measurement of platelet.', '', '3. AGE AT MEASUREMENT - This variable records the age of an individual at the time of measurement. It is more closely related to the new variable in terms of capturing age information.', '', 'SELECTED: AGE AT MEASUREMENT', 'ALIGNMENT: To align the new variable ""age at measurement of platelet_ncnc_bld (years)"" with the existing variable ""AGE AT MEASUREMENT,"" ensure that the age information for platelet measurement is recorded accurately at the time of measurement. This will help maintain consistency and harmonization with the existing variable capturing age at measurement.']",
age_at_platelet_ncnc_bld,age at measurement of platelet_ncnc_bld (years) (HARMONIZED),AGE (YRS) RECVD A TRANSFUSION OF PLATELE,16419,0.28866935,,
age_at_platelet_ncnc_bld,age at measurement of platelet_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.17981844,,
age_at_pmv_entvol_bld,age at measurement of pmv_entvol_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.19961987,"['Existing Variables:', '1. AGE AT MEASUREMENT - This variable represents the age at which the measurement was taken. It is a common demographic variable used in many studies to account for age-related differences in biological processes.', '2. AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25) - This variable is a calculated age at measurement based on a formula that converts days to years. It is likely used for standardizing age measurements across different studies or datasets.', '3. YEAR OF MEASUREMENT - This variable represents the calendar year in which the measurement was taken. It is important for tracking temporal trends and accounting for potential changes over time.', '', 'SELECTED: AGE AT MEASUREMENT', 'ALIGNMENT: To align the new variable ""age at measurement of pmv_entvol_bld (years) (HARMONIZED)"" with the selected existing variable ""AGE AT MEASUREMENT,"" you should ensure that the age values are recorded consistently in years for all individuals in the dataset. If the new variable is in a different format (e.g., days), you may need to convert it to years using a similar formula as the second existing variable provided. Additionally, make sure to document any transformations or calculations made to harmonize the data.']",
age_at_pmv_entvol_bld,age at measurement of pmv_entvol_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.12940273,,
age_at_pmv_entvol_bld,age at measurement of pmv_entvol_bld (years) (HARMONIZED),YEAR OF MEASUREMENT,258930,0.034880888,,
age_at_rbc_ncnc_bld,age at measurement of rbc_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.23335676,"['Existing Variables:', '1. AGE AT MEASUREMENT - This variable represents the age of the individual at the time of measurement. It is a common demographic variable used in various studies to understand the impact of age on different health outcomes.', ""2. AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25) - This variable seems to be a calculated age at measurement, possibly adjusted for specific study parameters. It may provide a more accurate representation of the individual's age at the time of measurement."", '3. RE91: B3A. AGE OF RBC PRODUCT - This variable represents the age of the red blood cell product. While not directly related to the age of the individual at the time of measurement, it could potentially provide insights into the quality of the blood sample.', '', 'SELECTED: AGE AT MEASUREMENT', 'ALIGNMENT: To align the new variable ""age at measurement of rbc_ncnc_bld (years)"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the measurement of the age of the red blood cell sample is consistent with the age of the individual at the time of measurement. This alignment will help maintain the integrity and accuracy of the data in the repository.']",
age_at_rbc_ncnc_bld,age at measurement of rbc_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.10248422,,
age_at_rbc_ncnc_bld,age at measurement of rbc_ncnc_bld (years) (HARMONIZED),RE91: B3A. AGE OF RBC PRODUCT,196115,0.06064055,,
age_at_rdw_ratio_rbc,age at measurement of rdw_ratio_rbc (years) (HARMONIZED),RDW (%),195309,0.20625381,"['Existing Variables:', '1. RDW (%) - Red Cell Distribution Width (RDW) is a measure of the variation in the size of red blood cells. It is often used as a marker of anemia and other blood disorders.', '2. AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25) - This variable represents the age at which the measurement was taken, converted from days to years for easier interpretation.', '3. RED CELL DISTRIBUTION WIDTH (RDW) (%) - This variable specifically refers to the Red Cell Distribution Width, which is a measure of the variation in red blood cell size.', '', 'SELECTED: RDW (%)', 'ALIGNMENT: To align the new variable ""age at measurement of rdw_ratio_rbc (years)"" with the existing variable RDW (%), you should ensure that the age at which the measurement was taken is accurately recorded in years. Additionally, the ratio of RDW to red blood cell count should be calculated and included in the variable to harmonize it with the existing RDW (%) variable. This will help maintain consistency and compatibility within the data repository.']",
age_at_rdw_ratio_rbc,age at measurement of rdw_ratio_rbc (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.09170696,,
age_at_rdw_ratio_rbc,age at measurement of rdw_ratio_rbc (years) (HARMONIZED),RED CELL DISTRIBUTION WIDTH (RDW) (%),199505,0.05997644,,
age_at_total_cholesterol,age at measurement of total_cholesterol (years) (HARMONIZED),TOTAL CHOLESTEROL 6 YEARS,236863,0.5590192,"['Existing Variables:', '1. TOTAL CHOLESTEROL 6 YEARS - This variable represents the total cholesterol level measured at 6 years.', '2. TOTAL CHOLESTEROL (MG/DL) AT YEAR 1 - This variable represents the total cholesterol level measured at year 1 in milligrams per deciliter.', '3. TOTAL CHOLESTEROL 2 YEARS - This variable represents the total cholesterol level measured at 2 years.', '', 'SELECTED: TOTAL CHOLESTEROL (MG/DL) AT YEAR 1', 'ALIGNMENT: To align the new variable ""age at measurement of total_cholesterol (years)"" with the selected existing variable ""TOTAL CHOLESTEROL (MG/DL) AT YEAR 1"", you should ensure that the measurement of total cholesterol is in milligrams per deciliter and corresponds to the measurement taken at year 1. This alignment will help maintain consistency and compatibility with the existing data in the repository.']",
age_at_total_cholesterol,age at measurement of total_cholesterol (years) (HARMONIZED),TOTAL CHOLESTEROL (MG/DL) AT YEAR 1,236845,0.5074343,,
age_at_total_cholesterol,age at measurement of total_cholesterol (years) (HARMONIZED),TOTAL CHOLESTEROL 2 YEARS,236861,0.40309682,,
age_at_triglycerides,age at measurement of triglycerides (HARMONIZED),AGE AT LIPID DETERMINATION,16674,0.2007143,"['Existing Variables:', '1. AGE AT LIPID DETERMINATION - This variable represents the age at which lipid levels were determined in the individual.', '2. AGE AT MEASUREMENT - This variable represents the age at which a particular measurement was taken.', '3. FASTING TRIGLYCERIDES (MG/DL) - This variable represents the level of triglycerides in the blood after a period of fasting, measured in milligrams per deciliter.', '', 'SELECTED: AGE AT MEASUREMENT', 'ALIGNMENT: To align the new variable ""age at measurement of triglycerides"" with the existing variable ""AGE AT MEASUREMENT,"" ensure that the age recorded for the measurement of triglycerides matches the age at which the measurement was taken. This will help maintain consistency in the dataset and make it easier to analyze relationships between age and triglyceride levels.']",
age_at_triglycerides,age at measurement of triglycerides (HARMONIZED),AGE AT MEASUREMENT,16680,0.13986565,,
age_at_triglycerides,age at measurement of triglycerides (HARMONIZED),FASTING TRIGLYCERIDES (MG/DL),92884,0.013480103,,
age_at_wbc_ncnc_bld,age at measurement of wbc_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.20577459,"['Existing Variables:', '1. AGE AT MEASUREMENT - This variable captures the age of the individual at the time of measurement, which is relevant for understanding the relationship between age and various biological factors.', '2. DATE OF WBC (DATE TO DAYS) - This variable provides the date of white blood cell measurement in days, which may be important for tracking temporal trends in biological variables.', '3. AGE AT MEASUREMENT ((MBCA2-DSRA4)/365.25) - This variable calculates the age at measurement based on specific study parameters, taking into account different variables for accurate age determination.', '', 'SELECTED: AGE AT MEASUREMENT', 'ALIGNMENT: To align the new variable ""age at measurement of WBC_ncnc_bld (years)"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the age recorded for the white blood cell measurement is in years. If the age is recorded in a different unit (e.g., months or days), convert it to years for consistency with the existing variable. Additionally, consider any study-specific adjustments or calculations needed to accurately determine the age at measurement in years.']",
age_at_wbc_ncnc_bld,age at measurement of wbc_ncnc_bld (years) (HARMONIZED),DATE OF WBC (DATE TO DAYS),61848,0.10932483,,
age_at_wbc_ncnc_bld,age at measurement of wbc_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.0946777,,
basophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of basophils in the blood (bld). (thousands / microliter) (HARMONIZED)","WHITE BLOOD COUNT, THOUSANDS PER MICROLITER",256039,0.5681163,"['Existing Variables:', '1. WHITE BLOOD CELL COUNT (X10/L) - This variable measures the total number of white blood cells per liter of blood, which is similar to the new variable that measures the count of basophils in thousands per microliter.', '2. WHITE BLOOD CELL COUNT - This variable also measures the total number of white blood cells, but the unit is not specified. It is relevant as it provides a general understanding of white blood cell counts.', '3. WHITE BLOOD COUNT, THOUSANDS PER MICROLITER - This variable specifically measures the white blood cell count in thousands per microliter, which aligns closely with the new variable that measures basophils count in the same unit.', '', 'SELECTED: WHITE BLOOD COUNT, THOUSANDS PER MICROLITER', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement unit is consistent (thousands per microliter) and specify that it pertains to basophils in the blood. This will harmonize the new variable with the existing variable for white blood cell count.']",
basophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of basophils in the blood (bld). (thousands / microliter) (HARMONIZED)",WHITE BLOOD CELL COUNT (X10/L),256004,0.18300885,,
basophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of basophils in the blood (bld). (thousands / microliter) (HARMONIZED)",WHITE BLOOD CELL COUNT,255992,0.14928317,,
eosinophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of eosinophils in the blood (bld). (thousands / microliter) (HARMONIZED)",EOSINOPHIL COUNT (X10^3/UL),82891,0.59819484,"['Existing Variables:', '1. CBC WITH DIFFERENTIAL CELL COUNT: EOSINOPHILS (ABSOLUTE COUNT) (0-9999/UL) - This existing variable provides information on the absolute count of eosinophils in the blood, which is similar to the new variable that also involves counting eosinophils in microliters.', '2. TOTAL EOSINOPHIL COUNT, CELLS/MICROLITER - This existing variable also measures the eosinophil count in microliters, aligning closely with the new variable.', '3. EOSINOPHIL COUNT (X10^3/UL) - This existing variable measures eosinophil count in microliters, albeit in a slightly different format.', '', 'SELECTED: CBC WITH DIFFERENTIAL CELL COUNT: EOSINOPHILS (ABSOLUTE COUNT) (0-9999/UL)', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the counting method and units used for measuring eosinophils in microliters are consistent. Additionally, consider any conversion factors necessary to harmonize the data accurately.']",
eosinophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of eosinophils in the blood (bld). (thousands / microliter) (HARMONIZED)",CBC WITH DIFFERENTIAL CELL COUNT: EOSINOPHILS (ABSOLUTE COUNT) (0-9999/UL),43565,0.5467079,,
eosinophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of eosinophils in the blood (bld). (thousands / microliter) (HARMONIZED)","TOTAL EOSINOPHIL COUNT, CELLS/MICROLITER",237142,0.26038945,,
hdl,Hdl cholesterol (mg/dl) (HARMONIZED),HDL-CHOLESTEROL (MG/DL),108809,0.65301627,"['Existing Variables:', '1. HDL-CHOLESTEROL (MG/DL) - This variable represents the measurement of high-density lipoprotein (HDL) cholesterol in milligrams per deciliter. It is a crucial indicator of cardiovascular health.', '2. HDL-C CHOLESTEROL (MG/DL) - This variable also measures high-density lipoprotein (HDL) cholesterol in milligrams per deciliter, providing similar information to the first existing variable.', '3. TOTAL HDL CHOLESTEROL (MG/DL) - This variable likely combines the measurement of different types of HDL cholesterol to provide a total value in milligrams per deciliter.', '', 'SELECTED: HDL-CHOLESTEROL (MG/DL)', 'ALIGNMENT: To align the new variable ""Hdl cholesterol (mg/dl) (HARMONIZED)"" with the selected existing variable ""HDL-CHOLESTEROL (MG/DL),"" ensure that the measurement units are consistent (milligrams per deciliter) and that the method of measurement and sample population are similar. It is important to follow standardized protocols for measuring HDL cholesterol to ensure accurate harmonization with existing data.']",
hdl,Hdl cholesterol (mg/dl) (HARMONIZED),HDL-C CHOLESTEROL (MG/DL),108807,0.6237207,,
hdl,Hdl cholesterol (mg/dl) (HARMONIZED),TOTAL HDL CHOLESTEROL (MG/DL),237299,0.5718264,,
hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD),110470,0.9404625,"['Existing Variables:', '1. HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD) - This variable represents the percentage of red blood cells in whole blood, which is a crucial measure of blood composition.', '2. BLOOD ANALYSIS: HEMATOCRIT - This variable likely includes detailed information about the hematocrit levels obtained from blood analysis, providing additional context to the measurement.', '3. HEMATOCRIT (HCT) (%) - This variable is another representation of hematocrit percentage, potentially offering different sources or methods of measurement.', '', 'SELECTED: HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD)', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement method and units used for calculating the fraction of volume of blood composed of red blood cells are consistent with the existing variable. Additionally, consider any specific guidelines or protocols related to hematocrit measurements to maintain harmonization with the repository data.']",
hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",BLOOD ANALYSIS: HEMATOCRIT,34250,0.9206471,,
hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",HEMATOCRIT (HCT) (%),110482,0.90397453,,
hemoglobin_mcnc_bld,"Measurement of mass per volume, or mass concentration (mcnc), of hemoglobin in the blood (bld). (g / dL = grams per deciliter) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)",143100,0.9418684,"['Existing Variables:', '1. MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL) - This variable represents the average concentration of hemoglobin in a given volume of packed red blood cells. It is measured in grams per deciliter (g/dL).', '2. MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC) (G/DL) - Similar to the first variable, this represents the mean concentration of hemoglobin in a specific volume of red blood cells.', '3. MEAN CELLULAR HEMOGLOBIN CONCENTRATION(GM/DL) - This variable also measures the concentration of hemoglobin in red blood cells, but in grams per deciliter.', '', 'SELECTED: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement of mass per volume of hemoglobin in the blood is calculated in grams per deciliter (g/dL) as well. This will harmonize the new variable with the existing variable representing the mean corpuscular hemoglobin concentration.']",
hemoglobin_mcnc_bld,"Measurement of mass per volume, or mass concentration (mcnc), of hemoglobin in the blood (bld). (g / dL = grams per deciliter) (HARMONIZED)",MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC) (G/DL),143098,0.81626,,
hemoglobin_mcnc_bld,"Measurement of mass per volume, or mass concentration (mcnc), of hemoglobin in the blood (bld). (g / dL = grams per deciliter) (HARMONIZED)",MEAN CELLULAR HEMOGLOBIN CONCENTRATION(GM/DL),143077,0.755637,,
ldl,Ldl cholesterol (mg/dl) (HARMONIZED),LDL CHOLESTEROL CALCULATED (MG/DL),131935,0.91165274,"['Existing Variables:', '1. LDL CHOLESTEROL CALCULATED (MG/DL) - This variable represents the calculated value of LDL cholesterol in milligrams per deciliter (mg/dL).', '2. LDL CHOLESTEROL (MG/DL) - This variable represents the direct measurement of LDL cholesterol in milligrams per deciliter (mg/dL).', '3. LDL-CHOLESTEROL (MG/DL) - This variable also represents the measurement of LDL cholesterol in milligrams per deciliter (mg/dL).', '', 'SELECTED: LDL CHOLESTEROL (MG/DL)', 'ALIGNMENT: To align the new variable ""Ldl cholesterol (mg/dl) (HARMONIZED)"" with the selected existing variable ""LDL CHOLESTEROL (MG/DL)"", ensure that the measurement units are consistent (mg/dL) and that the method of measurement is similar to ensure harmonization. Additionally, consider any potential differences in calculation methods if applicable.']",
ldl,Ldl cholesterol (mg/dl) (HARMONIZED),LDL CHOLESTEROL (MG/DL),131927,0.9092645,,
ldl,Ldl cholesterol (mg/dl) (HARMONIZED),LDL-CHOLESTEROL (MG/DL),131974,0.8929365,,
lymphocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of lymphocytes in the blood (bld). (thousands / microliter) (HARMONIZED)",LYMPHOCYTE COUNT (X10^3/UL),140055,0.12474515,"['Existing Variables:', '1. LYMPHOCYTE COUNT - This variable represents the count of lymphocytes in the blood.', '2. LYMPHOCYTE COUNT - This variable also represents the count of lymphocytes in the blood.', '3. LYMPHOCYTE COUNT (X10E9) - This variable represents the count of lymphocytes in the blood in units of billions.', '', 'SELECTED: LYMPHOCYTE COUNT', 'ALIGNMENT: To align the new variable ""Count by volume, or number concentration (ncnc), of lymphocytes in the blood (bld). (thousands / microliter)"" with the existing variable ""LYMPHOCYTE COUNT"", you should ensure that the units are consistent. Convert the new variable to represent the count of lymphocytes in the blood in the same units as the existing variable, which is typically in thousands per microliter. This will harmonize the new variable with the existing variable for easier comparison and analysis.']",
lymphocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of lymphocytes in the blood (bld). (thousands / microliter) (HARMONIZED)",LYMPHOCYTE COUNT,140052,0.10266401,,
lymphocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of lymphocytes in the blood (bld). (thousands / microliter) (HARMONIZED)",LYMPHOCYTE COUNT (X10E9),140053,0.09186978,,
mch_entmass_rbc,"Measurement of the average mass (entmass) of hemoglobin per red blood cell(rbc), known as mean corpuscular hemoglobin (MCH). (pg = picogram) (HARMONIZED)",MEAN CORPUSCULAR HEMOGLOBIN (MCH) (PG),143090,0.9863632,"['1. MEAN CORPUSCULAR HEMOGLOBIN (MCH) (PG) - This existing variable represents the measurement of the average mass of hemoglobin per red blood cell in picograms. It is directly related to the new variable describing mean corpuscular hemoglobin.', '', '2. MEAN CORPUSCULAR HEMOGLOBIN, MCH (PG) - This existing variable is similar to the new variable in that it also describes the mean corpuscular hemoglobin in picograms. It provides additional context and relevance to the new variable.', '', '3. MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL) - This existing variable represents the concentration of hemoglobin in the red blood cells. While related to hemoglobin, it is not directly measuring the average mass of hemoglobin per red blood cell like the new variable.', '', 'SELECTED: MEAN CORPUSCULAR HEMOGLOBIN (MCH) (PG)', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement units are consistent (picograms) and that the method of calculating the mean corpuscular hemoglobin is standardized across all data points. This will help harmonize the new variable with the existing variable in the data repository.']",
mch_entmass_rbc,"Measurement of the average mass (entmass) of hemoglobin per red blood cell(rbc), known as mean corpuscular hemoglobin (MCH). (pg = picogram) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN, MCH (PG)",143101,0.98538435,,
mch_entmass_rbc,"Measurement of the average mass (entmass) of hemoglobin per red blood cell(rbc), known as mean corpuscular hemoglobin (MCH). (pg = picogram) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)",143100,0.9481545,,
mchc_mcnc_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)",MCHC - MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION - NUMERIC VALUE G/DL,142510,0.98926485,"['1. MCHC - MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION - NUMERIC VALUE G/DL', 'This existing variable directly matches the description of the new variable, as both refer to the mean corpuscular hemoglobin concentration in grams per deciliter.', '', '2. CHCM (G/DL) - MEAN OF THE RBC HGB CONCENTRATION', 'While CHCM also relates to hemoglobin concentration, it specifically mentions the mean of the red blood cell hemoglobin concentration, which may not be an exact match for the new variable.', '', '3. MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)', 'This existing variable is essentially the same as the new variable, as it also describes the mean corpuscular hemoglobin concentration in grams per deciliter.', '', 'SELECTED: MCHC - MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION - NUMERIC VALUE G/DL', 'ALIGNMENT: To align the new variable with the selected existing variable MCHC, ensure that the measurement of the mass concentration of hemoglobin in packed red blood cells is calculated and reported in grams per deciliter (g/dL). This will harmonize the new variable with the existing MCHC variable in the data repository.']",
mchc_mcnc_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)",CHCM (G/DL) - MEAN OF THE RBC HGB CONCENTRATION,45928,0.9854964,,
mchc_mcnc_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)",143100,0.98141783,,
mcv_entvol_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)",MCHC - MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION - NUMERIC VALUE G/DL,142510,0.98926485,"['1. MCHC - MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION - NUMERIC VALUE G/DL', '2. CHCM (G/DL) - MEAN OF THE RBC HGB CONCENTRATION', '3. MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)', '', 'SELECTED: MCHC', 'ALIGNMENT: To align the new variable with the existing variable MCHC, ensure that the measurement of the mass concentration of hemoglobin in packed red blood cells is reported in grams per deciliter (g/dL). This will ensure consistency and harmonization with the existing variable in the data repository.']",
mcv_entvol_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)",CHCM (G/DL) - MEAN OF THE RBC HGB CONCENTRATION,45928,0.9854964,,
mcv_entvol_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)",143100,0.98141783,,
monocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of monocytes in the blood (bld). (HARMONIZED)",MONOCYTE COUNT,152746,0.4499968,"['Existing Variables:', '1. MONOCYTE COUNT - This variable represents the count of monocytes in the blood, which are a type of white blood cell that plays a role in the immune response.', '2. WHITE BLOOD CELL COUNT - This variable represents the total count of white blood cells in the blood, including monocytes.', '3. WHITE BLOOD CELL COUNT (MM3) - This variable represents the white blood cell count measured in cubic millimeters.', '', 'SELECTED: MONOCYTE COUNT', 'ALIGNMENT: To align the new variable with the existing ""MONOCYTE COUNT"" variable, ensure that the count by volume or number concentration of monocytes in the blood is specifically captured and reported in a similar manner as the existing variable. This may involve using the same units of measurement and ensuring that the counting method is consistent with how monocyte count is typically determined in the dataset. Additionally, consider any normalization or standardization procedures that are applied to the existing variable and apply them to the new variable as well. ', '', 'By aligning the new variable with the existing ""MONOCYTE COUNT"" variable, you can ensure consistency and compatibility within the data repository, making it easier to analyze and interpret the data in the context of monocyte levels in the blood.']",
monocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of monocytes in the blood (bld). (HARMONIZED)",WHITE BLOOD CELL COUNT,255992,0.23005374,,
monocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of monocytes in the blood (bld). (HARMONIZED)",WHITE BLOOD CELL COUNT (MM3),256002,0.22422527,,
neutrophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of neutrophils in the blood (bld). (HARMONIZED)",NEUTROPHIL COUNT (ANC),157930,0.33709443,"['Existing Variables:', '1. NEUTROPHIL COUNT (ANC) - This variable represents the count of neutrophils in the blood, typically measured as a percentage of white blood cells.', '2. ABSOLUTE NEUTROPHIL COUNT (ANC) - This variable represents the absolute count of neutrophils in the blood, providing a more accurate measurement by accounting for variations in total white blood cell count.', '3. II_3B ABSOLUTE NEUTROPHIL COUNT (ANC) - This variable seems to be a specific subtype or measurement method for absolute neutrophil count.', '', 'SELECTED: ABSOLUTE NEUTROPHIL COUNT (ANC)', 'ALIGNMENT: To align the new variable ""Count by volume, or number concentration (ncnc), of neutrophils in the blood (bld)"" with the selected existing variable ""ABSOLUTE NEUTROPHIL COUNT (ANC)"", you would need to ensure that the new variable provides an absolute count of neutrophils in the blood, rather than a percentage or relative count. This may involve converting the count by volume or number concentration to an absolute count by taking into account the total blood volume or concentration. Additionally, ensure that the measurement units and methods are consistent with those used for the existing variable for accurate harmonization.']",
neutrophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of neutrophils in the blood (bld). (HARMONIZED)",ABSOLUTE NEUTROPHIL COUNT (ANC),12042,0.33513322,,
neutrophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of neutrophils in the blood (bld). (HARMONIZED)",II_3B ABSOLUTE NEUTROPHIL COUNT (ANC),121311,0.25608712,,
platelet_ncnc_bld,"Count by volume, or number concentration (ncnc), of platelets in the blood (bld). (thousands / microliter) (HARMONIZED)","PLATELET COUNT, THOUSANDS PER MICROLITER",183333,0.95506835,"['Existing Variables:', '1. PLATELET COUNT, THOUSANDS PER MICROLITER - This variable represents the count of platelets in the blood in thousands per microliter. It is a common measurement used in clinical settings to assess platelet levels.', '2. PLATELET COUNT (1000/MM3) - This variable also represents the count of platelets in the blood, but in units of 1000 per cubic millimeter. It is another common measurement used in medical laboratories.', '3. PLATELET COUNT (10^9/L) - This variable represents platelet count in units of 10^9 per liter, which is another standard unit for measuring platelet levels.', '', 'SELECTED: PLATELET COUNT, THOUSANDS PER MICROLITER', 'ALIGNMENT: To align the new variable ""Count by volume, or number concentration (ncnc), of platelets in the blood (bld). (thousands / microliter)"" with the selected existing variable ""PLATELET COUNT, THOUSANDS PER MICROLITER"", you should ensure that the measurement units are consistent. Convert the new variable\'s platelet count to thousands per microliter to harmonize it with the existing variable. This will allow for seamless integration and comparison of the new variable with the existing data in the repository.']",
platelet_ncnc_bld,"Count by volume, or number concentration (ncnc), of platelets in the blood (bld). (thousands / microliter) (HARMONIZED)",PLATELET COUNT (1000/MM3),183280,0.9361684,,
platelet_ncnc_bld,"Count by volume, or number concentration (ncnc), of platelets in the blood (bld). (thousands / microliter) (HARMONIZED)",PLATELET COUNT (10^9/L),183283,0.8690492,,
pmv_entvol_bld,"Measurement of the mean volume (entvol) of platelets in the blood (bld), known as mean platelet volume (MPV or PMV). (fL = femtoliter) (HARMONIZED)",MPV - MEAN PLATELET VOLUME - NUMERIC VALUE FL,154727,0.9881766,"['Existing Variables:', '1. MPV - MEAN PLATELET VOLUME - NUMERIC VALUE FL', '2. MEAN PLATELET VOLUME, MPV (ΜM3)', '3. MEAN PLATELET VOLUME (FL)', '', 'SELECTED: MPV - MEAN PLATELET VOLUME - NUMERIC VALUE FL', 'ALIGNMENT: To align your new variable with the selected existing variable ""MPV - MEAN PLATELET VOLUME - NUMERIC VALUE FL"", ensure that the measurement of the mean volume of platelets in the blood is represented in femtoliters (fL) as this is the unit used in the existing variable. This will harmonize the new variable with the existing variable in the NHLBI data repository.']",
pmv_entvol_bld,"Measurement of the mean volume (entvol) of platelets in the blood (bld), known as mean platelet volume (MPV or PMV). (fL = femtoliter) (HARMONIZED)","MEAN PLATELET VOLUME, MPV (ΜM3)",144603,0.98072886,,
pmv_entvol_bld,"Measurement of the mean volume (entvol) of platelets in the blood (bld), known as mean platelet volume (MPV or PMV). (fL = femtoliter) (HARMONIZED)",MEAN PLATELET VOLUME (FL),144601,0.9757161,,
rbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of red blood cells in the blood (bld). (millions / microliter) (HARMONIZED)","RED BLOOD COUNT, MILLIONS PER MICROLITER",199494,0.9666632,"['Existing Variables:', '1. RED BLOOD CELL COUNT - This variable represents the number of red blood cells in a given volume of blood. It is typically measured in millions of cells per microliter.', '2. RED BLOOD CELL COUNT (MILLIONS CELLS/UL) - Similar to the previous variable, this represents the count of red blood cells in a microliter of blood.', '3. HEMOGLOBIN LEVEL - This variable measures the concentration of hemoglobin in the blood, which is an important component of red blood cells.', '', 'SELECTED: RED BLOOD CELL COUNT', 'ALIGNMENT: To align the new variable with the selected existing variable ""RED BLOOD CELL COUNT,"" ensure that the count of red blood cells in millions per microliter is accurately measured and reported. This will harmonize the new variable with the existing variable in the repository.']",
rbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of red blood cells in the blood (bld). (millions / microliter) (HARMONIZED)",RED BLOOD CELL COUNT,199474,0.8767399,,
rbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of red blood cells in the blood (bld). (millions / microliter) (HARMONIZED)",RED BLOOD CELL COUNT (MILLIONS CELLS/UL),199478,0.8715842,,
rdw_ratio_rbc,"Measurement of the ratio of variation in width to the mean width of the red blood cell (rbc) volume distribution curve taken at +/- 1 CV, known as red cell distribution width (RDW). (percentage) (HARMONIZED)",RDW - RED CELL DISTRIBUTION WIDTH - NUMERIC VALUE %,195310,0.99351174,"['1. RDW - RED CELL DISTRIBUTION WIDTH - NUMERIC VALUE %', '   - The existing variable RDW represents the red cell distribution width as a numeric value percentage, indicating the variation in width to the mean width of red blood cells.', '', '2. RED CELL DISTRIBUTION WIDTH (RDW) (%)', '   - This existing variable also represents the red cell distribution width as a percentage, providing a measure of the variation in red blood cell width.', '', '3. RED CELL DISTRIBUTION WIDTH, RDW (%)', '   - Similar to the other existing variables, this variable also describes the red cell distribution width as a percentage.', '', 'SELECTED: RDW - RED CELL DISTRIBUTION WIDTH - NUMERIC VALUE %', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement of the ratio of variation in width to the mean width of the red blood cell volume distribution curve is represented as a numeric value percentage. This will harmonize the new variable with the existing variable RDW.']",
rdw_ratio_rbc,"Measurement of the ratio of variation in width to the mean width of the red blood cell (rbc) volume distribution curve taken at +/- 1 CV, known as red cell distribution width (RDW). (percentage) (HARMONIZED)",RED CELL DISTRIBUTION WIDTH (RDW) (%),199505,0.99010193,,
rdw_ratio_rbc,"Measurement of the ratio of variation in width to the mean width of the red blood cell (rbc) volume distribution curve taken at +/- 1 CV, known as red cell distribution width (RDW). (percentage) (HARMONIZED)","RED CELL DISTRIBUTION WIDTH, RDW (%)",199507,0.9896718,,
total_cholesterol,Total cholesterol (mg/dl) (HARMONIZED),TOTAL CHOLESTEROL (MG/DL),236841,0.9360516,"['1. TOTAL CHOLESTEROL (MG/DL) - This existing variable represents the total cholesterol level in milligrams per deciliter, which is a common measurement used in clinical settings to assess cardiovascular risk.', '', '2. TOTAL CHOLESTEROL (MG-DL) - This existing variable is similar to the first one, representing total cholesterol in milligrams per deciliter. The slight difference in formatting (hyphen vs. slash) may be due to data entry variations.', '', '3. TOTAL HDL CHOLESTEROL (MG/DL) - This existing variable specifically represents the high-density lipoprotein (HDL) cholesterol level in milligrams per deciliter, which is an important component of total cholesterol and is often used to assess cardiovascular health.', '', 'SELECTED: TOTAL CHOLESTEROL (MG/DL)', 'ALIGNMENT: To align your new variable ""Total cholesterol (mg/dl) (HARMONIZED)"" with the selected existing variable ""TOTAL CHOLESTEROL (MG/DL),"" ensure that the measurement unit is consistent (milligrams per deciliter) and that the variable accurately reflects the total cholesterol level in the dataset. Consider any potential data entry variations and harmonize the formatting for consistency.']",
total_cholesterol,Total cholesterol (mg/dl) (HARMONIZED),TOTAL CHOLESTEROL (MG-DL),236839,0.9136765,,
total_cholesterol,Total cholesterol (mg/dl) (HARMONIZED),TOTAL HDL CHOLESTEROL (MG/DL),237299,0.84221536,,
triglycerides,Triglycerides (mg/dl) (HARMONIZED),TOTAL TRIGLYCERIDES (MG/DL),238621,0.5616356,"['Existing Variables:', '1. TOTAL TRIGLYCERIDES (MG/DL) - This variable represents the total amount of triglycerides in milligrams per deciliter of blood. It is commonly used in clinical settings to assess lipid levels.', '2. TOTAL TRIGLYCERIDES (MG-DL) - Similar to the first variable, this also represents the total amount of triglycerides in milligrams per deciliter of blood.', '3. NON-FASTING TRIGLYCERIDES (MG/DL) - This variable specifically indicates the level of triglycerides in the blood when the individual has not fasted prior to the test. ', '', 'SELECTED: TOTAL TRIGLYCERIDES (MG/DL)', 'ALIGNMENT: To align the new variable ""Triglycerides (mg/dl) (HARMONIZED)"" with the selected existing variable ""TOTAL TRIGLYCERIDES (MG/DL)"", ensure that the measurement unit is consistent (mg/dl) and that the variable captures the total amount of triglycerides in the blood. Additionally, consider any specific guidelines or protocols related to measuring and reporting triglyceride levels in the dataset to ensure harmonization.']",
triglycerides,Triglycerides (mg/dl) (HARMONIZED),TOTAL TRIGLYCERIDES (MG-DL),238620,0.5201764,,
triglycerides,Triglycerides (mg/dl) (HARMONIZED),NON-FASTING TRIGLYCERIDES (MG/DL),160094,0.3599264,,
unit_basophil_ncnc_bld,"harmonization unit for basophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HYPERSEGMENTED NEUTROPHILS (LABA63),117756,0.97813547,"['Existing Variables:', '1. HYPERSEGMENTED NEUTROPHILS (LABA63) - This variable describes a specific type of neutrophil morphology in a blood sample. While it is related to blood cell morphology, it may not directly align with the new variable as it focuses on a different type of white blood cell.', '2. OBSERVATION UNIT - This variable likely refers to the unit of measurement or observation for a particular variable. It may not be directly relevant to harmonizing the new variable related to basophil counts.', '3. PROCALCITONIN UNIT - This variable likely refers to the unit of measurement for procalcitonin levels in the blood. It is related to biomarker measurements in the blood, but may not align directly with the new variable on basophil counts.', '', 'SELECTED: None', 'RATIONALE: None of the existing variables directly align with the new variable on harmonization unit for basophil counts. It appears that a suitable existing variable for harmonization may not be present in the current pool.', '', 'ALIGNMENT: Since none of the existing variables are a good fit for harmonizing the new variable, it may be necessary to consult with domain experts or researchers familiar with basophil counts to determine the best approach for aligning the new variable with the existing data in the repository. This could involve creating a new harmonization unit or identifying additional variables that could be used as reference points for harmonization.']",
unit_basophil_ncnc_bld,"harmonization unit for basophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.97399324,,
unit_basophil_ncnc_bld,"harmonization unit for basophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PROCALCITONIN UNIT,187463,0.9642542,,
unit_eosinophil_ncnc_bld,"harmonization unit for eosinophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.95195264,"['Existing Variables:', '1. OBSERVATION UNIT - This variable describes the unit of observation in the dataset, such as individual patients, samples, or time points. It is important for organizing and analyzing data based on the unit of measurement.', '2. HYPERSEGMENTED NEUTROPHILS (LABA63) - This variable represents a specific laboratory measurement related to the presence of hypersegmented neutrophils in the blood. It is a quantitative measure of a specific cell type in the blood.', '3. PROCALCITONIN UNIT - This variable indicates the unit of measurement for procalcitonin levels in the dataset. Procalcitonin is a biomarker used in clinical settings to assess inflammation and infection.', '', 'SELECTED: OBSERVATION UNIT', 'ALIGNMENT: To align the new variable ""harmonization unit for eosinophil_ncnc_bld"" with the existing variable ""OBSERVATION UNIT,"" you should consider defining a clear and consistent unit of observation for the harmonization process. This could involve grouping subjects based on similar characteristics or study parameters to ensure that the harmonization is done effectively across different datasets. Additionally, documenting the criteria for defining the harmonization unit and ensuring that it is applied consistently throughout the data harmonization process will help align the new variable with the existing ""OBSERVATION UNIT.""']",
unit_eosinophil_ncnc_bld,"harmonization unit for eosinophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HYPERSEGMENTED NEUTROPHILS (LABA63),117756,0.9452985,,
unit_eosinophil_ncnc_bld,"harmonization unit for eosinophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PROCALCITONIN UNIT,187463,0.9417614,,
unit_hdl,"harmonization unit for hdl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",C_HDL,57197,0.99720997,"['Existing Variables:', '1. C_HDL - This variable represents the concentration of high-density lipoprotein (HDL) cholesterol in the blood. It is a crucial marker for assessing cardiovascular health.', '2. LN(HDL) - This variable represents the natural logarithm of the HDL cholesterol concentration. It is often used for statistical analysis to normalize the data distribution.', '3. HEMOGLOBIN UNIT - This variable represents the unit of measurement for hemoglobin, which is a protein in red blood cells that carries oxygen. It is essential for understanding blood oxygen levels.', '', 'SELECTED: C_HDL', 'ALIGNMENT: To align the new variable ""harmonization unit for HDL"" with the existing variable C_HDL, you should ensure that the harmonization unit is based on the concentration of HDL cholesterol in the blood. This can involve standardizing the measurement units, ensuring consistency in data collection methods, and following established guidelines for assessing HDL cholesterol levels in research studies. Additionally, consider incorporating any necessary adjustments or transformations to make the new variable compatible with the existing C_HDL variable for accurate data analysis and interpretation.']",
unit_hdl,"harmonization unit for hdl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",LN(HDL),136423,0.99703056,,
unit_hdl,"harmonization unit for hdl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEMOGLOBIN UNIT,110764,0.99554896,,
unit_hematocrit_vfr_bld,"harmonization unit for hematocrit_vfr_bld. (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEMATOCRIT UNIT,110516,0.99716616,"['Existing Variables:', '1. HEMATOCRIT UNIT - This variable likely represents the unit of measurement for hematocrit levels in the blood.', '2. UNITS - HCT - This variable may provide information on the units used to measure hematocrit levels.', '3. HAEMOGLOBIN UNIT - This variable could be related to the unit of measurement for hemoglobin levels in the blood.', '', 'SELECTED: HEMATOCRIT UNIT', 'ALIGNMENT: To align the new variable ""harmonization unit for hematocrit_vfr_bld"" with the existing variable ""HEMATOCRIT UNIT,"" ensure that the harmonization unit is consistent with the unit of measurement for hematocrit levels in the blood. This may involve confirming that the same units are used and that the definitions align with each other. Additionally, consider any specific guidelines or standards related to harmonization units for hematocrit levels.']",
unit_hematocrit_vfr_bld,"harmonization unit for hematocrit_vfr_bld. (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - HCT,243059,0.9867261,,
unit_hematocrit_vfr_bld,"harmonization unit for hematocrit_vfr_bld. (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HAEMOGLOBIN UNIT,105983,0.98255754,,
unit_hemoglobin_mcnc_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD),110470,0.9404625,"['Existing Variables:', '1. HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD) - This variable represents the percentage of red blood cells in whole blood, which is a crucial measure of blood composition.', '2. BLOOD ANALYSIS: HEMATOCRIT - This variable likely contains detailed information related to hematocrit levels obtained from blood analysis, providing additional context to the measurement.', '3. HEMATOCRIT (HCT) (%) - Another representation of hematocrit percentage, which aligns with the new variable description.', '', 'SELECTED: HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD)', 'ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement method and units used for calculating the percentage of red blood cells in whole blood are consistent with the existing variable. Additionally, consider any specific guidelines or protocols related to hematocrit measurements to maintain harmonization within the data repository.']",
unit_hemoglobin_mcnc_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",BLOOD ANALYSIS: HEMATOCRIT,34250,0.9206471,,
unit_hemoglobin_mcnc_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",HEMATOCRIT (HCT) (%),110482,0.90397453,,
unit_ldl,"harmonization unit for ldl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",LDH UNIT,131898,0.9847524,"['Existing Variables:', '1. LDH UNIT - This variable represents the units for LDH (lactate dehydrogenase) levels, which can be measured in U/L or %.', '2. UNITS FOR LDH2:A=U/L,B=%) - This variable specifies the units for LDH2 levels, which can be in U/L or %.', '3. TOTAL CHOLESTEROL UNIT - This variable indicates the units for total cholesterol levels, which are typically measured in mg/dL or mmol/L.', '', 'SELECTED: LDH UNIT', 'ALIGNMENT: To align the new variable ""harmonization unit for ldl"" with the existing variable LDH UNIT, you should consider using the same units of measurement (U/L or %) for LDL levels. This will ensure consistency in data representation and facilitate comparisons across different subjects. Additionally, you may need to define specific criteria for grouping subjects into harmonization units based on their LDL phenotypes.']",
unit_ldl,"harmonization unit for ldl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)","UNITS FOR LDH2:A=U/L,B=%)",243078,0.97850823,,
unit_ldl,"harmonization unit for ldl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.97046465,,
unit_lymphocyte_ncnc_bld,"harmonization unit for lymphocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WBC UNIT,251820,0.99424744,"['Existing Variables:', '1. WBC UNIT - This variable represents the unit of measurement for white blood cell count. It is important for standardizing the measurement of white blood cells in the blood.', '2. LYMPHOCYTE (10^3/UL) [7/15/95] - This variable specifically refers to the count of lymphocytes in the blood, measured in thousands per microliter. Lymphocytes are a type of white blood cell that plays a key role in the immune system.', '3. # HLA MATCHED UNITS - This variable likely pertains to the number of units that are matched for human leukocyte antigen (HLA) compatibility, which is important in organ transplantation to reduce the risk of rejection.', '', 'SELECTED: LYMPHOCYTE (10^3/UL) [7/15/95]', 'ALIGNMENT: To align the new variable ""harmonization unit for lymphocyte_ncnc_bld"" with the existing variable ""LYMPHOCYTE (10^3/UL) [7/15/95]"", ensure that the measurement units for lymphocyte count are consistent (e.g., both in thousands per microliter). Additionally, consider the date format provided in the existing variable to maintain consistency in data representation. This alignment will help in harmonizing the new variable with the existing data in the repository.']",
unit_lymphocyte_ncnc_bld,"harmonization unit for lymphocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",LYMPHOCYTE (10^3/UL) [7/15/95],140050,0.98742366,,
unit_lymphocyte_ncnc_bld,"harmonization unit for lymphocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",# HLA MATCHED UNITS,348,0.98191,,
unit_mch_entmass_rbc,"harmonization unit for mch_entmass_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCHC,243063,0.9963783,"['Existing Variables:', '1. UNITS - MCHC (Mean Corpuscular Hemoglobin Concentration) - This variable measures the average concentration of hemoglobin in a red blood cell. It is relevant to the new variable as it also involves hemoglobin and red blood cells.', '2. UNITS - RBC (Red Blood Cell Count) - This variable measures the number of red blood cells in a specific volume of blood. It is relevant to the new variable as it also involves red blood cells.', '3. UNITS - MCH (Mean Corpuscular Hemoglobin) - This variable measures the average amount of hemoglobin in a red blood cell. It is relevant to the new variable as it also involves hemoglobin and red blood cells.', '', 'SELECTED: UNITS - MCH', 'ALIGNMENT: To align the new variable ""harmonization unit for mch_entmass_rbc"" with the existing variable ""UNITS - MCH"", you should ensure that the measurement units and processing methods for mean corpuscular hemoglobin are consistent between the two variables. This may involve standardizing the units of measurement, ensuring the same calculation methods are used, and verifying that the data collection processes are similar. Additionally, it would be beneficial to consult with domain experts to confirm the harmonization process.']",
unit_mch_entmass_rbc,"harmonization unit for mch_entmass_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RBC,243068,0.9961755,,
unit_mch_entmass_rbc,"harmonization unit for mch_entmass_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCH,243062,0.99586606,,
unit_mchc_mcnc_rbc,"harmonization unit for mchc_mcnc_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCHC,243063,0.9980277,"['Existing Variables:', '1. UNITS - MCHC (Mean Corpuscular Hemoglobin Concentration): This variable represents the concentration of hemoglobin in a given volume of packed red blood cells. It is a crucial measure in assessing anemia and other blood disorders.', '2. UNITS - MCH (Mean Corpuscular Hemoglobin): This variable represents the average amount of hemoglobin in a single red blood cell. It is another important measure in evaluating anemia and other blood conditions.', '3. MCHC UNIT: This variable likely specifies the unit of measurement for Mean Corpuscular Hemoglobin Concentration.', '', 'SELECTED: UNITS - MCHC', 'ALIGNMENT: To align the new variable ""harmonization unit for mchc_mcnc_rbc"" with the existing variable ""UNITS - MCHC,"" ensure that the harmonization unit for MCHC and MCH (Mean Corpuscular Hemoglobin) are consistent. This involves using the same units of measurement for both variables to maintain data integrity and facilitate comparisons across different subjects. Additionally, consider any conversion factors or adjustments needed to harmonize the new variable with the existing ""UNITS - MCHC"" variable.']",
unit_mchc_mcnc_rbc,"harmonization unit for mchc_mcnc_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCH,243062,0.99703056,,
unit_mchc_mcnc_rbc,"harmonization unit for mchc_mcnc_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.99648935,,
unit_mcv_entvol_rbc,"harmonization unit for mcv_entvol_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCHC,243063,0.9972531,"['Existing Variables:', '1. UNITS - MCHC: This variable likely represents the units used to measure Mean Corpuscular Hemoglobin Concentration (MCHC), which is a measure of the average concentration of hemoglobin in a given volume of packed red blood cells. ', '2. UNITS - RBC: This variable likely represents the units used to measure Red Blood Cell (RBC) count, which is a measure of the number of red blood cells in a given volume of blood.', '3. MCHC UNIT: This variable likely represents the unit of measurement specifically for Mean Corpuscular Hemoglobin Concentration (MCHC).', '', 'SELECTED: UNITS - MCHC', 'ALIGNMENT: To align the new variable ""harmonization unit for mcv_entvol_rbc"" with the selected existing variable ""UNITS - MCHC"", ensure that the units used for measuring the mean corpuscular volume (MCV) of red blood cells are consistent with the units used for measuring MCHC. This alignment will help ensure that the data is harmonized and can be compared accurately within the repository.']",
unit_mcv_entvol_rbc,"harmonization unit for mcv_entvol_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RBC,243068,0.99708784,,
unit_mcv_entvol_rbc,"harmonization unit for mcv_entvol_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.9957684,,
unit_monocyte_ncnc_bld,"harmonization unit for monocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WBC UNIT,251820,0.9953544,"['Existing Variables:', '1. WBC UNIT - This variable likely represents the unit of measurement for white blood cell count, which is a common parameter in blood tests to assess immune system health.', '2. MCHC UNIT - This variable likely represents the unit of measurement for mean corpuscular hemoglobin concentration, which is a parameter used to evaluate the concentration of hemoglobin in red blood cells.', '3. # HLA MATCHED UNITS - This variable likely represents the number of human leukocyte antigen (HLA) matched units, which is important in organ and tissue transplantation to reduce the risk of rejection.', '', 'SELECTED: WBC UNIT', 'ALIGNMENT: To align the new variable ""harmonization unit for monocyte_ncnc_bld"" with the existing variable ""WBC UNIT,"" you should ensure that the unit of measurement for the harmonization unit is consistent with the unit used for white blood cell count. This will help in standardizing the data and making it easier to compare and analyze across different studies. Additionally, consider any conversion factors that may be needed to convert between different units of measurement if necessary.']",
unit_monocyte_ncnc_bld,"harmonization unit for monocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.98131067,,
unit_monocyte_ncnc_bld,"harmonization unit for monocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",# HLA MATCHED UNITS,348,0.9801293,,
unit_neutrophil_ncnc_bld,"harmonization unit for neutrophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WBC UNIT,251820,0.9947392,"['Existing Variables:', '1. WBC UNIT - This variable likely describes the unit of measurement for white blood cell count. It is important to ensure consistency in units when harmonizing variables.', '2. UNITS - WBC - This variable may provide additional information on the units used for white blood cell count, which can be crucial for harmonization purposes.', '3. HYPERSEGMENTED NEUTROPHILS (LABA63) - This variable may be related to a specific type of white blood cell, which could be relevant when harmonizing variables related to white blood cell counts.', '', 'SELECTED: WBC UNIT', 'ALIGNMENT: To align the new variable ""harmonization unit for neutrophil_ncnc_bld"" with the existing variable ""WBC UNIT,"" ensure that the unit of measurement for white blood cell count is consistent across both variables. This may involve converting units if necessary or clearly documenting any differences in units between the two variables. Additionally, consider any specific processing methods or definitions for the harmonization unit to ensure alignment with the existing variable.']",
unit_neutrophil_ncnc_bld,"harmonization unit for neutrophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - WBC,243072,0.99411184,,
unit_neutrophil_ncnc_bld,"harmonization unit for neutrophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HYPERSEGMENTED NEUTROPHILS (LABA63),117756,0.97150993,,
unit_platelet_ncnc_bld,"harmonization unit for platelet_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PLATELETS UNIT,183488,0.9962492,"['Existing Variables:', '1. PLATELETS UNIT - This variable likely refers to the unit of measurement used for platelet counts in blood samples.', '2. PLATELETS UNITS - This variable may also refer to the unit of measurement used for platelet counts in blood samples, but with a slightly different naming convention.', ""3. PATIENT'S PLATELET PHENOTYPE - This variable likely describes the specific characteristics or traits of a patient's platelets."", '', 'SELECTED: PLATELETS UNIT', 'ALIGNMENT: To align the new variable ""harmonization unit for platelet_ncnc_bld"" with the existing variable ""PLATELETS UNIT,"" you should ensure that the unit of measurement for platelet counts in the harmonization unit is consistent with the unit used in the existing variable. Additionally, consider any specific guidelines or conventions for defining and recording platelet counts in the dataset. ', '', 'By selecting ""PLATELETS UNIT"" as the best fit, you can ensure that the new variable aligns well with the existing variables in the data repository, facilitating data harmonization and analysis.']",
unit_platelet_ncnc_bld,"harmonization unit for platelet_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PLATELETS UNITS,183489,0.99556625,,
unit_platelet_ncnc_bld,"harmonization unit for platelet_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PATIENT'S PLATELET PHENOTYPE,178508,0.99408895,,
unit_pmv_entvol_bld,"harmonization unit for pmv_entvol_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MPV,243066,0.99619037,"['Existing Variables:', '1. UNITS - This variable likely describes the units of measurement for a particular variable. It could be relevant for harmonizing the new variable if it also involves units of measurement.', '2. OBSERVATION UNIT - This variable may describe the unit of observation for a particular variable. It could be relevant for harmonizing the new variable if it involves similar observational units.', '3. MPV - This variable could represent Mean Platelet Volume, which is a measure of the average size of platelets in the blood. It may be relevant for harmonizing the new variable if it is related to blood volume or platelet characteristics.', '', 'SELECTED: UNITS', 'ALIGNMENT: To align the new variable ""harmonization unit for pmv_entvol_bld"" with the existing variable ""UNITS"", you should ensure that the units of measurement for blood volume are consistent and clearly defined. This will help in harmonizing the new variable with existing data in the repository.']",
unit_pmv_entvol_bld,"harmonization unit for pmv_entvol_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.97706646,,
unit_pmv_entvol_bld,"harmonization unit for pmv_entvol_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.97666925,,
unit_rbc_ncnc_bld,"harmonization unit for rbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RBC,243068,0.99815416,"['Existing Variables:', '1. ABO GROUP OF RBC UNIT - This variable describes the ABO blood group of the red blood cell unit. It is relevant as it provides information on the blood type of the red blood cells.', '2. NUCLEATED RBCS - This variable describes the presence of nucleated red blood cells. It is relevant as it provides information on the type of red blood cells present.', '', 'SELECTED: ABO GROUP OF RBC UNIT', 'ALIGNMENT: To align the new variable ""harmonization unit for rbc_ncnc_bld"" with the existing variable ""ABO GROUP OF RBC UNIT,"" you can ensure that the subjects in the harmonization unit are categorized based on their ABO blood group. This will help in harmonizing the new variable with the existing variable by grouping subjects with similar ABO blood groups together.']",
unit_rbc_ncnc_bld,"harmonization unit for rbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",B4. ABO GROUP OF RBC UNIT,30085,0.9963783,,
unit_rbc_ncnc_bld,"harmonization unit for rbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",NUCLEATED RBCS,161411,0.9927672,,
unit_rdw_ratio_rbc,"harmonization unit for rdw_ratio_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RDW,243069,0.99592984,"['Existing Variables:', '1. UNITS - RDW: This variable likely represents the units used to measure Red Cell Distribution Width (RDW), which is a measure of the variation in red blood cell size. It is relevant to the new variable as it involves RDW.', '2. UNITS - RBC: This variable likely represents the units used to measure Red Blood Cells (RBC), which are responsible for carrying oxygen in the blood. It is relevant to the new variable as it involves RBC.', '3. HEMATOLOGY RBC SI UNITS: This variable likely represents the standardized international units used in hematology for Red Blood Cells (RBC). It is relevant to the new variable as it involves RBC.', '', 'SELECTED: UNITS - RDW', 'ALIGNMENT: To align the new variable ""harmonization unit for rdw_ratio_rbc"" with the existing variable ""UNITS - RDW"", ensure that the units used for the RDW ratio in the new variable are consistent with the units specified in the existing variable. This will help maintain uniformity and compatibility within the data repository.']",
unit_rdw_ratio_rbc,"harmonization unit for rdw_ratio_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RBC,243068,0.98942953,,
unit_rdw_ratio_rbc,"harmonization unit for rdw_ratio_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEMATOLOGY RBC SI UNITS,110561,0.9705206,,
unit_total_cholesterol,"harmonization unit for total_cholesterol (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.9938549,"['Existing Variables:', '1. TOTAL CHOLESTEROL UNIT - This variable likely represents the unit of measurement for total cholesterol levels, such as mg/dL or mmol/L.', '2. TOTAL CHOLESTEROL UNITS - This variable may also represent the unit of measurement for total cholesterol levels, similar to the first existing variable.', '3. TOTAL CHOLESTEROL - This variable likely represents the actual total cholesterol levels in the blood.', '', 'SELECTED: TOTAL CHOLESTEROL', 'ALIGNMENT: To align the new variable ""harmonization unit for total_cholesterol"" with the selected existing variable ""TOTAL CHOLESTEROL,"" you should ensure that the harmonization unit is consistent with the measurement unit used for total cholesterol levels. Additionally, you should consider using the same data format and range as the existing variable to maintain consistency in the data repository.']",
unit_total_cholesterol,"harmonization unit for total_cholesterol (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNITS,236880,0.9917484,,
unit_total_cholesterol,"harmonization unit for total_cholesterol (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL.,236912,0.99135584,,
unit_triglycerides,"harmonization unit for triglycerides (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TRIGLYCERIDES IN SI UNITS,240630,0.9762653,"['Existing Variables:', '1. TRIGLYCERIDES IN SI UNITS - This variable represents the measurement of triglycerides in the International System of Units (SI), which is a standard unit of measurement used in scientific research.', '2. TOTAL CHOLESTEROL UNIT - This variable represents the measurement unit for total cholesterol levels in the blood, which is another important biomarker for cardiovascular health.', '3. TOTAL CHOLESTEROL UNITS - This variable likely refers to the units used to measure total cholesterol levels, similar to the previous variable.', '', 'SELECTED: TRIGLYCERIDES IN SI UNITS', 'ALIGNMENT: To align the new variable ""harmonization unit for triglycerides"" with the existing variable ""TRIGLYCERIDES IN SI UNITS,"" you should ensure that the harmonization unit is also measured in the SI units system. This will allow for consistency and comparability with the existing data in the repository. Additionally, it is important to follow any specific guidelines or protocols for measuring and reporting triglyceride levels to ensure accurate harmonization with the existing variable.']",
unit_triglycerides,"harmonization unit for triglycerides (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.9683214,,
unit_triglycerides,"harmonization unit for triglycerides (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNITS,236880,0.9596866,,
unit_wbc_ncnc_bld,"harmonization unit for wbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - WBC,243072,0.9983451,"['Existing Variables:', '1. WBC UNIT - This variable likely represents the units in which white blood cell (WBC) count is measured. It is relevant to the new variable as it may provide information on how the WBC count is reported.', '2. WBC - This variable likely represents the actual white blood cell count. It is relevant to the new variable as it is directly related to the measurement being harmonized.', '3. MCHC UNIT - This variable likely represents the units in which mean corpuscular hemoglobin concentration (MCHC) is measured. While not directly related to WBC, it may provide insights into unit standardization within the dataset.', '', 'SELECTED: WBC', 'ALIGNMENT: To align the new variable ""harmonization unit for wbc_ncnc_bld"" with the existing variable ""WBC"", you should ensure that the harmonization unit is consistent with the measurement and reporting of white blood cell counts. This may involve standardizing the units used, ensuring data quality and accuracy, and following any established guidelines for reporting WBC counts in the dataset.']",
unit_wbc_ncnc_bld,"harmonization unit for wbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WBC UNIT,251820,0.9974689,,
unit_wbc_ncnc_bld,"harmonization unit for wbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.98761624,,
wbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of white blood cells in the blood (bld). (thousands / microliter) (HARMONIZED)","WHITE BLOOD COUNT, THOUSANDS PER MICROLITER",256039,0.95877,"['Existing Variables:', '1. WHITE BLOOD CELL COUNT - This variable represents the count of white blood cells in the blood.', '2. TOTAL WHITE BLOOD COUNT (WBC X 1000) - This variable also represents the total count of white blood cells in the blood, but it is multiplied by 1000.', '3. WHITE BLOOD COUNT, THOUSANDS PER MICROLITER - This variable specifically indicates the count of white blood cells in thousands per microliter of blood.', '', 'SELECTED: WHITE BLOOD COUNT, THOUSANDS PER MICROLITER', 'ALIGNMENT: To align the new variable with ""WHITE BLOOD COUNT, THOUSANDS PER MICROLITER,"" ensure that the count of white blood cells is measured in thousands per microliter of blood. This will harmonize the new variable with the existing variable in the repository.']",
wbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of white blood cells in the blood (bld). (thousands / microliter) (HARMONIZED)",WHITE BLOOD CELL COUNT,255992,0.8822251,,
wbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of white blood cells in the blood (bld). (thousands / microliter) (HARMONIZED)",TOTAL WHITE BLOOD COUNT (WBC X 1000),239224,0.831143,,
age_at_antihypertensive_meds,age at measurement of antihypertensive_meds (years) (HARMONIZED),"HYPERTENSION MEDS, AGE STARTED USE",117820,0.22337706,"['1. HYPERTENSION MEDS, AGE STARTED USE - These variables provide information on the use of antihypertensive medications and the age at which they were started. This can help in understanding the treatment history of individuals with hypertension.', '', '2. HYPERTENSION (AGE) - This variable indicates the presence of hypertension and the age at which it was diagnosed. Understanding the age at which hypertension was diagnosed can provide insights into the progression of the condition.', '', '3. AGE HYPERTENSION - This variable provides information on the age of individuals with hypertension. It can help in analyzing the relationship between age and the development of hypertension.', '', 'SELECTED: HYPERTENSION (AGE)', 'ALIGNMENT: To align the new variable ""age at measurement of antihypertensive_meds"" with the existing variable ""HYPERTENSION (AGE)"", you can ensure that the age at which antihypertensive medications were measured corresponds to the age at which hypertension was diagnosed. This alignment can help in harmonizing the new variable with the existing variable by establishing a clear relationship between age and hypertension diagnosis.']",
age_at_antihypertensive_meds,age at measurement of antihypertensive_meds (years) (HARMONIZED),HYPERTENSION (AGE),117769,0.12189466,,
age_at_antihypertensive_meds,age at measurement of antihypertensive_meds (years) (HARMONIZED),AGE HYPERTENSION,17076,0.09434341,,
age_at_fasting_lipids,age at measurement of fasting_lipids (years) (HARMONIZED),AGE AT DIAGNOSIS (YRS) - LIPIDS,16569,0.66974485,"['Existing Variables:', '1. AGE AT DIAGNOSIS (YRS) - LIPIDS: This variable captures the age at which a diagnosis related to lipids was made, which may not directly align with the age at which lipid measurements were taken.', '2. AGE AT LIPID DETERMINATION: This variable specifically captures the age at which lipid measurements were determined, which is more closely related to the new variable.', '3. FASTING: TOTAL CHOLESTEROL: This variable represents the measurement of total cholesterol levels in the fasting state, which is related to lipid measurements but does not directly capture the age at which the measurement was taken.', '', 'SELECTED: AGE AT LIPID DETERMINATION', 'ALIGNMENT: To align the new variable ""age at measurement of fasting_lipids (years)"" with the existing variable ""AGE AT LIPID DETERMINATION,"" ensure that the age recorded for the lipid measurement corresponds to the age at which the fasting lipid levels were determined. This will help harmonize the new variable with the existing variable in the data repository.']",
age_at_fasting_lipids,age at measurement of fasting_lipids (years) (HARMONIZED),AGE AT LIPID DETERMINATION,16674,0.32584226,,
age_at_fasting_lipids,age at measurement of fasting_lipids (years) (HARMONIZED),FASTING: TOTAL CHOLESTEROL,92892,0.078078166,,
age_at_lipid_lowering_medication,age at measurement of age_at_lipid1c (years) (HARMONIZED),AGE AT DIAGNOSIS (YRS) - LIPIDS,16569,0.6579781,"['Existing Variables:', '1. AGE AT DIAGNOSIS (YRS) - LIPIDS: This variable captures the age at which a diagnosis related to lipids was made. It provides information on the age of onset or detection of lipid-related issues.', '2. AGE AT LIPID DETERMINATION: This variable indicates the age at which lipid levels were determined or measured. It is relevant for understanding the timing of lipid assessments in relation to age.', '3. TOTAL CHOLESTEROL (MG/DL) AT YEAR 1: This variable represents the total cholesterol levels measured in milligrams per deciliter at the first year of assessment. It gives insight into the lipid profile at a specific time point.', '', 'SELECTED: AGE AT LIPID DETERMINATION', 'ALIGNMENT: To align the new variable ""age at measurement of age_at_lipid1c (years)"" with the existing variable ""AGE AT LIPID DETERMINATION,"" ensure that the age recorded for the measurement of lipid levels corresponds to the age at which the lipid determination was made. This alignment will help maintain consistency in the timing of lipid assessments in the dataset.']",
age_at_lipid_lowering_medication,age at measurement of age_at_lipid1c (years) (HARMONIZED),AGE AT LIPID DETERMINATION,16674,0.32852945,,
age_at_lipid_lowering_medication,age at measurement of age_at_lipid1c (years) (HARMONIZED),TOTAL CHOLESTEROL (MG/DL) AT YEAR 1,236845,0.04401865,,
antihypertensive_meds,Indicator for use of antihypertensive medication at the time of blood pressure measurement. (HARMONIZED),HISTORY OF HYPERTENSION INDICATOR,112509,0.761893,"[""1. HISTORY OF HYPERTENSION INDICATOR - This existing variable indicates whether an individual has a history of hypertension. It is relevant to the new variable as it provides information on the individual's past medical condition related to hypertension."", '', '2. SYSTOLIC BLOOD PRESSURE, READING #1 AT WITHDRAW DATE OF ANTIHYPERTENSIVE MEDICATION - This existing variable captures the systolic blood pressure reading at the time of withdrawal of antihypertensive medication. While it is related to hypertension and medication, it may not directly align with the new variable that focuses on the use of antihypertensive medication at the time of blood pressure measurement.', '', '3. HOUR OF TIME OF BLOOD PRESSURE MEASUREMENT - This existing variable indicates the hour at which the blood pressure measurement was taken. While it provides information on the timing of the measurement, it does not directly relate to the use of antihypertensive medication at the time of measurement.', '', 'SELECTED: HISTORY OF HYPERTENSION INDICATOR', 'ALIGNMENT: To align the new variable ""Indicator for use of antihypertensive medication at the time of blood pressure measurement"" with the existing variable ""HISTORY OF HYPERTENSION INDICATOR,"" you can consider incorporating the history of hypertension as a factor in determining the use of antihypertensive medication at the time of blood pressure measurement. This alignment can help provide a comprehensive understanding of the individual\'s medical history and current medication status in relation to hypertension.']",
antihypertensive_meds,Indicator for use of antihypertensive medication at the time of blood pressure measurement. (HARMONIZED),"SYSTOLIC BLOOD PRESSURE, READING #1 AT WITHDRAW DATE OF ANTIHYPERTENSIVE MEDICATION",229129,0.38462317,,
antihypertensive_meds,Indicator for use of antihypertensive medication at the time of blood pressure measurement. (HARMONIZED),HOUR OF TIME OF BLOOD PRESSURE MEASUREMENT,114107,0.31195062,,
fasting_lipids,Indicates whether participant fasted for at least eight hours prior to blood draw to measure lipids phenotypes. (HARMONIZED),DID SUBJECT FAST PRIOR TO LIPID COLLECTION?,70874,0.83223665,"['Existing Variables:', '1. DID SUBJECT FAST PRIOR TO LIPID COLLECTION? - This variable indicates whether the subject fasted prior to lipid collection, which is relevant to the new variable as it directly relates to the timing of the blood draw in relation to fasting.', '2. FASTING TIME OF 8 HOURS OR MORE - This variable specifically captures the fasting time of 8 hours or more, which is crucial for lipid measurements and aligns closely with the concept of fasting prior to lipid collection.', '3. V5 FASTING TIME OF 8 HOURS OR MORE - This variable also captures the fasting time of 8 hours or more, similar to the second existing variable, and is relevant for lipid measurements.', '', 'SELECTED: FASTING TIME OF 8 HOURS OR MORE', ""ALIGNMENT: To align the new variable with the selected existing variable, ensure that the definition and criteria for fasting time of 8 hours or more are consistent with the new variable's description of participant fasting for at least eight hours prior to blood draw for lipid phenotypes. This alignment will help maintain consistency and accuracy in capturing the fasting status of participants in relation to lipid measurements.""]",
fasting_lipids,Indicates whether participant fasted for at least eight hours prior to blood draw to measure lipids phenotypes. (HARMONIZED),FASTING TIME OF 8 HOURS OR MORE,92879,0.46377817,,
fasting_lipids,Indicates whether participant fasted for at least eight hours prior to blood draw to measure lipids phenotypes. (HARMONIZED),V5 FASTING TIME OF 8 HOURS OR MORE,245083,0.40739235,,
hypertension_meds,Take medication for hypertension (HARMONIZED),MEDICATION FOR HIGH BP/HYPERTENSION,146554,0.6078378,"['Existing Variables:', '1. MEDICATION FOR HIGH BP/HYPERTENSION - This variable indicates whether an individual is taking medication for high blood pressure or hypertension.', '2. HYPERTENSION MEDICATION - This variable specifies the type of medication being taken for hypertension.', '3. REGULAR MEDICATION FOR HYPERTENSION - This variable indicates if the medication for hypertension is taken regularly.', '', 'SELECTED: HYPERTENSION MEDICATION', 'ALIGNMENT: To align the new variable ""Take medication for hypertension"" with the existing variable ""HYPERTENSION MEDICATION,"" ensure that the new variable captures the specific type of medication being taken for hypertension. This alignment will provide more detailed information and enhance the harmonization process within the data repository.']",
hypertension_meds,Take medication for hypertension (HARMONIZED),HYPERTENSION MEDICATION,117816,0.46198756,,
hypertension_meds,Take medication for hypertension (HARMONIZED),REGULAR MEDICATION FOR HYPERTENSION,199960,0.36240488,,
lipid_lowering_medication,Any lipid-lowering medication (HARMONIZED),ANY LIPID-LOWERING MEDICATION,21559,0.86511016,"['Existing Variables:', '1. ANY LIPID-LOWERING MEDICATION - This variable likely captures any type of medication used to lower lipids in the body, such as statins, fibrates, or bile acid sequestrants.', '2. LIPID LOWERING MEDS - This variable specifically focuses on medications that are used to lower lipids in the body.', '3. HYPOLIPIDEMICS (LIPID LOWERING MEDS) - This variable also pertains to medications that lower lipids, indicating a similar concept to the new variable.', '', 'SELECTED: ANY LIPID-LOWERING MEDICATION', 'ALIGNMENT: To align the new variable ""Any lipid-lowering medication"" with the selected existing variable ""ANY LIPID-LOWERING MEDICATION,"" ensure that the new variable captures all types of medications used to lower lipids in the body. This includes statins, fibrates, bile acid sequestrants, and any other relevant medications in this category. Make sure to harmonize the terminology and definitions to match those used in the existing variable for consistency in the data repository.']",
lipid_lowering_medication,Any lipid-lowering medication (HARMONIZED),LIPID LOWERING MEDS,135787,0.8044059,,
lipid_lowering_medication,Any lipid-lowering medication (HARMONIZED),HYPOLIPIDEMICS (LIPID LOWERING MEDS),117956,0.5307078,,
unit_antihypertensive_meds,"harmonization unit for antihypertensive_meds (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MEDICATION UNIT,146894,0.9862577,"['Existing Variables:', '1. MEDICATION UNIT - This variable likely represents the unit of measurement for medications, such as milligrams or milliliters.', '2. UNITS OF MEDICATION 7 - This variable may represent a specific unit of measurement for a particular type of medication.', '3. UNITS OF MEDICATION 2 - This variable may also represent a specific unit of measurement for a different type of medication.', '', 'SELECTED: MEDICATION UNIT', 'ALIGNMENT: To align the new variable ""harmonization unit for antihypertensive_meds"" with the existing variable ""MEDICATION UNIT,"" you should ensure that the harmonization unit is consistent with the units of measurement used for medications in the repository. This may involve standardizing the units of measurement for antihypertensive medications to match those used in the ""MEDICATION UNIT"" variable. Additionally, you should consider any specific guidelines or conventions for recording medication units in the repository to ensure accurate and consistent data harmonization.']",
unit_antihypertensive_meds,"harmonization unit for antihypertensive_meds (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS OF MEDICATION 7,243090,0.9805806,,
unit_antihypertensive_meds,"harmonization unit for antihypertensive_meds (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS OF MEDICATION 2,243085,0.9793541,,
unit_fasting_lipids,"harmonization unit for fasting_lipids (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)","FASTING LIPIDS, TRIGLYCERIDE",92857,0.9980582,"['Existing Variables:', '1. FASTING LIPIDS - This variable likely includes measurements of various lipids in the blood taken after a period of fasting. It is relevant to the new variable as it involves lipid measurements.', '2. HDL-1ST COMPLETE LIPIDS - This variable specifically refers to high-density lipoprotein (HDL) measurements in the blood. It is relevant to the new variable as it is a component of lipid measurements.', '3. TOTAL CHOLESTEROL UNIT - This variable likely represents the unit of measurement for total cholesterol levels in the blood. While not specific to fasting lipids, it is relevant as cholesterol is a type of lipid.', '', 'SELECTED: FASTING LIPIDS', 'ALIGNMENT: To align the new variable with the existing variable ""FASTING LIPIDS,"" ensure that the measurements being collected for the harmonization unit are related to lipid levels in the blood taken after a period of fasting. This will help maintain consistency and comparability with the existing data in the repository.']",
unit_fasting_lipids,"harmonization unit for fasting_lipids (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HDL-1ST COMPLETE LIPIDS,108789,0.9916842,,
unit_fasting_lipids,"harmonization unit for fasting_lipids (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.9250947,,
unit_lipid_lowering_medication,"harmonization unit for unit_lipid1c (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HDL-1ST COMPLETE LIPIDS,108789,0.99010193,"['Existing Variables:', '1. HDL-1ST COMPLETE LIPIDS - This existing variable is relevant as it pertains to lipid levels in the blood, which may be related to the new variable involving lipid harmonization.', '2. MCHC UNIT - This existing variable is not directly related to lipid levels, so it may not be the best fit for harmonizing the new variable.', '3. TOTAL CHOLESTEROL UNIT - This existing variable is also relevant as it relates to cholesterol levels in the blood, which could be related to the new variable involving lipid harmonization.', '', 'SELECTED: HDL-1ST COMPLETE LIPIDS', 'ALIGNMENT: To align the new variable with HDL-1ST COMPLETE LIPIDS, ensure that the harmonization unit for unit_lipid1c is consistent with the measurement units and processing methods used for HDL-1ST COMPLETE LIPIDS. This may involve standardizing measurement techniques, units, and any other relevant factors to ensure harmonization across variables.']",
unit_lipid_lowering_medication,"harmonization unit for unit_lipid1c (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.9360516,,
unit_lipid_lowering_medication,"harmonization unit for unit_lipid1c (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.91196686,,
